Cattle
Beef Cattle (Feedlot)
Calves
Cattle (Multiple Classes)
Dairy Cattle
Growing Cattle
Reproducing Beef Cattle
Marketing Status - The following guide explains the marketing status categories used in the tables below:
- OTC - Product is in over-the-counter marketing status and is not impacted by Guidance for Industry #213 (GFI #213)
- VFD - Product is in Veterinary Feed Directive Status.
| Active Ingredient | Proprietary Name | NADA/ANADA | Label Type | Indications | Marketing Status |
|---|---|---|---|---|---|
| Bacitracin Methylene Disalicylate | PENNITRACIN | N141-137 | Type B | For reduction in the number of liver condemnations due to abscesses in beef steers and heifers fed in confinement for slaughter. | OTC |
| Bacitracin Methylene Disalicylate | PENNITRACIN | N141-137 | Type C | For reduction in the number of liver condemnations due to abscesses in beef steers and heifers fed in confinement for slaughter. | OTC |
| Bacitracin Methylene Disalicylate | PENNITRACIN | N141-137 | Type B | For reduction in the number of liver condemnations due to abscesses in beef steers and heifers fed in confinement for slaughter. | OTC |
| Bacitracin Methylene Disalicylate | PENNITRACIN | N141-137 | Type C | For reduction in the number of liver condemnations due to abscesses in beef steers and heifers fed in confinement for slaughter. | OTC |
| Bacitracin Methylene Disalicylate | BMD 30 | N046-592 | Type B | For reduction in the number of liver condemnations due to abscesses in feedlot beef cattle. | OTC |
| Bacitracin Methylene Disalicylate | BMD 30 | N046-592 | Type C | For reduction in the number of liver condemnations due to abscesses in feedlot beef cattle. | OTC |
| Bacitracin Methylene Disalicylate | BMD 30 | N046-592 | Type B | For reduction in the number of liver condemnations due to abscesses in feedlot beef cattle. | OTC |
| Bacitracin Methylene Disalicylate | BMD 30 | N046-592 | Type C | For reduction in the number of liver condemnations due to abscesses in feedlot beef cattle. | OTC |
| Chlortetracycline | CHLORMAX | N046-699 | Type C | For control of active infection of anaplasmosis caused by Anaplasma marginale susceptible to chlortetracycline in beef cattle over 700 lbs. | VFD (Effective 1/1/17) |
| Chlortetracycline | CHLORMAX | N046-699 | Type C | For the control of active infection of anaplasmosis caused by Anaplasma marginale susceptible to chlortetracycline in beef cattle under 700 pounds. | VFD (Effective 1/1/17) |
| Chlortetracycline | CHLORMAX | N046-699 | Type C | For the control of bacterial pneumonia associated with shipping fever complex caused by Pasteurella spp. susceptible to chlortetracycline in beef cattle. | VFD (Effective 1/1/17) |
| Chlortetracycline | CLTC | N092-286 | Type C | For beef cattle (over 700 lb) for control of active infection of anaplasmosis caused by A. marginale susceptible to chlortetracycline. | VFD (Effective 1/1/17) |
| Chlortetracycline | CLTC | N092-286 | Type C | For beef cattle (under 700 lb) for control of active infection of anaplasmosis caused by A. marginale susceptible to chlortetracycline. | VFD (Effective 1/1/17) |
| Chlortetracycline | CLTC | N092-286 | Type C | For beef cattle control of bacterial pneumonia associated with shipping fever complex caused by Pasteurella spp. susceptible to chlortetracycline. | VFD (Effective 1/1/17) |
| Chlortetracycline | AUREOMYCIN | N048-761 | Type B | For the control of active infection of anaplasmosis caused by Anaplasma marginale susceptible to chlortetracycline in beef cattle under 700 pounds. | VFD (Effective 1/1/17) |
| Chlortetracycline | AUREOMYCIN | N048-761 | Type C | For the control of active infection of anaplasmosis caused by Anaplasma marginale susceptible to chlortetracycline in beef cattle under 700 pounds. | VFD (Effective 1/1/17) |
| Chlortetracycline | AUREOMYCIN | N048-761 | Type B | For the control of active infection of anaplasmosis caused by Anaplasma marginale susceptible to chlortetracycline in beef cattle over 700 lbs. | VFD (Effective 1/1/17) |
| Chlortetracycline | AUREOMYCIN | N048-761 | Type C | For the control of active infection of anaplasmosis caused by Anaplasma marginale susceptible to chlortetracycline in beef cattle over 700 lbs. | VFD (Effective 1/1/17) |
| Chlortetracycline | AUREOMYCIN | N048-761 | Type B | For the control of bacterial pneumonia associated with shipping fever complex caused by Pasteurella spp. susceptible to chlortetracycline in beef cattle. | VFD (Effective 1/1/17) |
| Chlortetracycline | AUREOMYCIN | N048-761 | Type C | For the control of bacterial pneumonia associated with shipping fever complex caused by Pasteurella spp. susceptible to chlortetracycline in beef cattle. | VFD (Effective 1/1/17) |
| Chlortetracycline | AUREOMYCIN | N048-761 | Type B | VFD (Effective 1/1/17) | |
| Chlortetracycline | AUREOMYCIN | N048-761 | Type C | For the reduction of the incidence of liver abscesses in growing cattle over 400 lbs. | VFD (Effective 1/1/17) |
| Chlortetracycline | CHLORATET | N048-480 | Type B | For beef cattle weighing over 700 lb: Control of active infection of anaplasmosis caused by Anaplasma marginale susceptible to chlortetracycline. | VFD (Effective 1/1/17) |
| Chlortetracycline | CHLORATET | N048-480 | Type C | For beef cattle weighing over 700 lb: Control of active infection of anaplasmosis caused by Anaplasma marginale susceptible to chlortetracycline. | VFD (Effective 1/1/17) |
| Chlortetracycline | CHLORATET | N048-480 | Type B | For the control of active infection of anaplasmosis caused by Anaplasma marginale susceptible to chlortetracycline in beef cattle under 700 lb | VFD (Effective 1/1/17) |
| Chlortetracycline | CHLORATET | N048-480 | Type C | For the control of active infection of anaplasmosis caused by Anaplasma marginale susceptible to chlortetracycline in beef cattle under 700 lb | VFD (Effective 1/1/17) |
| Chlortetracycline | CHLORATET | N048-480 | Type B | For the control of bacterial pneumonia associated with shipping fever complex caused by Pasteurella spp. susceptible to chlortetracycline. | VFD (Effective 1/1/17) |
| Chlortetracycline | CHLORATET | N048-480 | Type C | For the control of bacterial pneumonia associated with shipping fever complex caused by Pasteurella spp. susceptible to chlortetracycline. | VFD (Effective 1/1/17) |
| Chlortetracycline | PENNCHLOR | N138-935 | Type C | For the control of active infection of anaplasmosis caused by Anaplasma marginale susceptible to chlortetracycline in beef cattle under 700 lbs and for the control of bacterial pneumonia associated with shipping fever complex by Pasteurella spp. susceptible to chlortetracycline in beef cattle. | VFD (Effective 1/1/17) |
| Chlortetracycline | PENNCHLOR | N138-935 | Type C | For the control of active infection of anaplasmosis caused by Anaplasma marginale susceptible to chlortetracycline in beef cattle over 700 lbs. | VFD (Effective 1/1/17) |
| Chlortetracycline | DERACIN | A200-510 | Type B | For the control of active infection of anaplasmosis caused by Anaplasma marginale susceptible to chlortetracycline in beef cattle under 700 pounds. | VFD (Effective 1/1/17) |
| Chlortetracycline | DERACIN | A200-510 | Type C | For the control of active infection of anaplasmosis caused by Anaplasma marginale susceptible to chlortetracycline in beef cattle under 700 pounds. | VFD (Effective 1/1/17) |
| Chlortetracycline | DERACIN | A200-510 | Type B | For the control of active infection of anaplasmosis caused by Anaplasma marginale susceptible to chlortetracycline in beef cattle over 700 lbs. | VFD (Effective 1/1/17) |
| Chlortetracycline | DERACIN | A200-510 | Type C | For the control of active infection of anaplasmosis caused by Anaplasma marginale susceptible to chlortetracycline in beef cattle over 700 lbs. | VFD (Effective 1/1/17) |
| Chlortetracycline | DERACIN | A200-510 | Type B | For the control of bacterial pneumonia associated with shipping fever complex caused by Pasteurella spp. susceptible to chlortetracycline in beef cattle. | VFD (Effective 1/1/17) |
| Chlortetracycline | DERACIN | A200-510 | Type C | For the control of bacterial pneumonia associated with shipping fever complex caused by Pasteurella spp. susceptible to chlortetracycline in beef cattle. | VFD (Effective 1/1/17) |
| Chlortetracycline, Lasalocid | AUREOMYCIN 100 PLUS | N141-250 | Type B | For the control of coccidiosis caused by Eimeria bovis and Eimeria zuernii and for control of active infection of anaplasmosis caused by Anaplasma marginale susceptible to chlortetracycline in beef cattle under 700 pounds. | VFD (Effective 1/1/17) |
| Chlortetracycline, Lasalocid | AUREOMYCIN 100 PLUS | N141-250 | Type C | For the control of coccidiosis caused by Eimeria bovis and Eimeria zuernii and for control of active infection of anaplasmosis caused by Anaplasma marginale susceptible to chlortetracycline in beef cattle under 700 pounds. | VFD (Effective 1/1/17) |
| Chlortetracycline, Lasalocid | AUREOMYCIN 100 PLUS | N141-250 | Type B | For improved feed efficiency and for control of active infection of anaplasmosis caused by Anaplasma marginale susceptible to chlortetracycline in cattle under 700 pounds fed in confinement for slaughter. | VFD (Effective 1/1/17) |
| Chlortetracycline, Lasalocid | AUREOMYCIN 100 PLUS | N141-250 | Type C | For improved feed efficiency and for control of active infection of anaplasmosis caused by Anaplasma marginale susceptible to chlortetracycline in cattle under 700 pounds fed in confinement for slaughter. | VFD (Effective 1/1/17) |
| Chlortetracycline, Lasalocid | AUREOMYCIN 100 PLUS | N141-250 | Type B | For improved feed efficiency, increased rate of weight gain and for control of active infection of anaplasmosis caused by Anaplasma marginale susceptible to chlortetracycline in cattle under 700 pounds fed in confinement for slaughter. | VFD (Effective 1/1/17) |
| Chlortetracycline, Lasalocid | AUREOMYCIN 100 PLUS | N141-250 | Type C | For improved feed efficiency, increased rate of weight gain and for control of active infection of anaplasmosis caused by Anaplasma marginale susceptible to chlortetracycline in cattle under 700 pounds fed in confinement for slaughter. | VFD (Effective 1/1/17) |
| Chlortetracycline, Lasalocid | AUREOMYCIN 100 PLUS | N141-250 | Type B | For the control of coccidiosis caused by Eimeria bovis and Eimeria zuernii and for the treatment of bacterial enteritis caused by E. coli and bacterial pneumonia caused by P. multocida organisms susceptible to chlortetracycline in cattle weighing up to 800 pounds. | VFD (Effective 1/1/17) |
| Chlortetracycline, Lasalocid | AUREOMYCIN 100 PLUS | N141-250 | Type C | For the control of coccidiosis caused by Eimeria bovis and Eimeria zuernii and for the treatment of bacterial enteritis caused by E. coli and bacterial pneumonia caused by P. multocida organisms susceptible to chlortetracycline in cattle weighing up to 800 pounds. | VFD (Effective 1/1/17) |
| Chlortetracycline, Lasalocid | AUREOMYCIN 100 PLUS | N141-250 | Type B | For improved feed efficiency and for the treatment of bacterial enteritis caused by E. coli and bacterial pneumonia caused by P. multocida organisms susceptible to chlortetracycline in cattle fed in confinement for slaughter. | VFD (Effective 1/1/17) |
| Chlortetracycline, Lasalocid | AUREOMYCIN 100 PLUS | N141-250 | Type C | For improved feed efficiency and for the treatment of bacterial enteritis caused by E. coli and bacterial pneumonia caused by P. multocida organisms susceptible to chlortetracycline in cattle fed in confinement for slaughter. | VFD (Effective 1/1/17) |
| Chlortetracycline, Lasalocid | AUREOMYCIN 100 PLUS | N141-250 | Type B | For improved feed efficiency, increased rate of weight gain and for the treatment of bacterial enteritis caused by E. coli and bacterial pneumonia caused by P. multocida organisms susceptible to chlortetracycline in cattle fed in confinement for slaughter. | VFD (Effective 1/1/17) |
| Chlortetracycline, Lasalocid | AUREOMYCIN 100 PLUS | N141-250 | Type C | For improved feed efficiency, increased rate of weight gain and for the treatment of bacterial enteritis caused by E. coli and bacterial pneumonia caused by P. multocida organisms susceptible to chlortetracycline in cattle fed in confinement for slaughter. | VFD (Effective 1/1/17) |
| Chlortetracycline, Lasalocid | AUREOMYCIN 100 PLUS | N141-250 | Type B | For increased rate of weight gain and for control of active infection of anaplasmosis caused by Anaplasma marginale susceptible to chlortetracycline in pasture cattle under 700 pounds (slaughter, stocker, feeder cattle, beef replacement heifers). | VFD (Effective 1/1/17) |
| Chlortetracycline, Lasalocid | AUREOMYCIN 100 PLUS | N141-250 | Type C | For increased rate of weight gain and for control of active infection of anaplasmosis caused by Anaplasma marginale susceptible to chlortetracycline in pasture cattle under 700 pounds (slaughter, stocker, feeder cattle, beef replacement heifers). | VFD (Effective 1/1/17) |
| Chlortetracycline, Lasalocid | AUREOMYCIN 100 PLUS | N141-250 | Type B | For increased rate of weight gain and for control of active infection of anaplasmosis caused by Anaplasma marginale susceptible to chlortetracycline in pasture cattle over 700 pounds (slaughter, stocker, feeder cattle, beef replacement heifers). | VFD (Effective 1/1/17) |
| Chlortetracycline, Lasalocid | AUREOMYCIN 100 PLUS | N141-250 | Type C | For increased rate of weight gain and for control of active infection of anaplasmosis caused by Anaplasma marginale susceptible to chlortetracycline in pasture cattle over 700 pounds (slaughter, stocker, feeder cattle, beef replacement heifers). | VFD (Effective 1/1/17) |
| Chlortetracycline, Lasalocid | AUREOMYCIN 100 PLUS | N141-250 | Type B | For increased rate of weight gain and for the treatment of bacterial enteritis caused by E. coli and bacterial pneumonia caused by P. multocida organisms susceptible to chlortetracycline in pasture cattle (slaughter, stocker, feeder cattle, dairy and beef replacement heifers). | VFD (Effective 1/1/17) |
| Chlortetracycline, Lasalocid | AUREOMYCIN 100 PLUS | N141-250 | Type C | For increased rate of weight gain and for the treatment of bacterial enteritis caused by E. coli and bacterial pneumonia caused by P. multocida organisms susceptible to chlortetracycline in pasture cattle (slaughter, stocker, feeder cattle, dairy and beef replacement heifers). | VFD (Effective 1/1/17) |
| Chlortetracycline, Lasalocid | AUREOMYCIN 100 PLUS | N141-250 | Type B | For the control of coccidiosis caused by Eimeria bovis and Eimeria zuernii and for control of bacterial pneumonia associated with shipping fever complex caused by Pasteurella spp. susceptible to chlortetracycline in beef cattle weighing up to 800 pounds. | VFD (Effective 1/1/17) |
| Chlortetracycline, Lasalocid | AUREOMYCIN 100 PLUS | N141-250 | Type C | For the control of coccidiosis caused by Eimeria bovis and Eimeria zuernii and for control of bacterial pneumonia associated with shipping fever complex caused by Pasteurella spp. susceptible to chlortetracycline in beef cattle weighing up to 800 pounds. | VFD (Effective 1/1/17) |
| Chlortetracycline, Lasalocid | AUREOMYCIN 100 PLUS | N141-250 | Type B | For improved feed efficiency and for control of bacterial pneumonia associated with shipping fever complex caused by Pasteurella spp. susceptible to chlortetracycline in cattle fed in confinement for slaughter. | VFD (Effective 1/1/17) |
| Chlortetracycline, Lasalocid | AUREOMYCIN 100 PLUS | N141-250 | Type C | For improved feed efficiency and for control of bacterial pneumonia associated with shipping fever complex caused by Pasteurella spp. susceptible to chlortetracycline in cattle fed in confinement for slaughter. | VFD (Effective 1/1/17) |
| Chlortetracycline, Lasalocid | AUREOMYCIN 100 PLUS | N141-250 | Type B | For improved feed efficiency, increased rate of weight gain and for control of bacterial pneumonia associated with shipping fever complex caused by Pasteurella spp. susceptible to chlortetracycline in cattle fed in confinement for slaughter. | VFD (Effective 1/1/17) |
| Chlortetracycline, Lasalocid | AUREOMYCIN 100 PLUS | N141-250 | Type C | For improved feed efficiency, increased rate of weight gain and for control of bacterial pneumonia associated with shipping fever complex caused by Pasteurella spp. susceptible to chlortetracycline in cattle fed in confinement for slaughter. | VFD (Effective 1/1/17) |
| Chlortetracycline, Lasalocid | AUREOMYCIN 100 PLUS | N141-250 | Type B | For increased rate of weight gain and for control of bacterial pneumonia associated with shipping fever complex caused by Pasteurella spp. susceptible to chlortetracycline in pasture cattle (slaughter, stocker, feeder cattle, beef replacement heifers). | VFD (Effective 1/1/17) |
| Chlortetracycline, Lasalocid | AUREOMYCIN 100 PLUS | N141-250 | Type C | For increased rate of weight gain and for control of bacterial pneumonia associated with shipping fever complex caused by Pasteurella spp. susceptible to chlortetracycline in pasture cattle (slaughter, stocker, feeder cattle, beef replacement heifers). | VFD (Effective 1/1/17) |
| Chlortetracycline, Lasalocid | DERACIN PLUS BOVATEC | A200-617 | Type B | For the control of coccidiosis caused by Eimeria bovis and Eimeria zuemii and for the treatment of bacterial enteritis caused by E. coli and bacterial pneumonia caused by P. multocida organisms susceptible to chlortetracycline in cattle weighing up to 800 pounds. | VFD (Effective 1/1/17) |
| Chlortetracycline, Lasalocid | DERACIN PLUS BOVATEC | A200-617 | Type C | For improved feed efficiency and for the treatment of bacterial enteritis caused by E. coli and bacterial pneumonia caused by P. multocida organisms susceptible to chlortetracycline in cattle fed in confinement for slaughter. | VFD (Effective 1/1/17) |
| Chlortetracycline, Lasalocid | DERACIN PLUS BOVATEC | A200-617 | Type C | For improved feed efficiency, increased rate of weight gain and for the treatment of bacterial enteritis caused by E. coli and bacterial pneumonia caused by P. multocida organisms susceptible to chlortetracycline in cattle fed in confinement for slaughter. | VFD (Effective 1/1/17) |
| Chlortetracycline, Lasalocid | DERACIN PLUS BOVATEC | A200-617 | Type C | For increased rate of weight gain and for the treatment of bacterial enteritis caused by E. coli and bacterial pneumonia caused by P. multocida organisms susceptible to chlortetracycline in pasture cattle (slaughter, stocker, feeder cattle, dairy and beef replacement heifers). | VFD (Effective 1/1/17) |
| Chlortetracycline, Lasalocid | DERACIN PLUS BOVATEC | A200-617 | Type C | For the control of coccidiosis caused by Eimeria bovis and Eimeria zuemii and for the treatment of bacterial enteritis caused by E. coli and bacterial pneumonia caused by P. multocida organisms susceptible to chlortetracycline in cattle weighing up to 800 pounds. | VFD (Effective 1/1/17) |
| Chlortetracycline, Lasalocid | DERACIN PLUS BOVATEC | A200-617 | Type C | For increased rate of weight gain and for control of active infection of anaplasmosis caused by Anaplasma marginale susceptible to chlortetracycline in pasture cattle over 700 pounds (slaughter, stocker, feeder cattle, beef replacement heifers). | VFD (Effective 1/1/17) |
| Chlortetracycline, Lasalocid | DERACIN PLUS BOVATEC | A200-617 | Type C | For the control of coccidiosis caused by Eimeria bovis and Eimeria zuernii and for control of active infection of anaplasmosis caused by Anaplasma marginale susceptible to chlortetracycline in beef cattle under 700 pounds. | VFD (Effective 1/1/17) |
| Decoquinate, Monensin sodium, Tylosin | DECCOX, RUMENSIN, TYLAN | N141-149 | Type B | For the prevention of coccidiosis caused by Eimeria bovis and E. zuernii, for improved feed efficiency, and for reduction of incidence of liver abscesses associated with Fusobacterium necrophorum and Arcanobacterium pyogenes in cattle fed in confinement for slaughter. | VFD (Effective 1/1/17) |
| Decoquinate, Monensin sodium, Tylosin | DECCOX, RUMENSIN, TYLAN | N141-149 | Type C | For the prevention of coccidiosis caused by Eimeria bovis and E. zuernii, for improved feed efficiency, and for reduction of incidence of liver abscesses associated with Fusobacterium necrophorum and Arcanobacterium pyogenes in cattle fed in confinement for slaughter. | VFD (Effective 1/1/17) |
| Decoquinate, Monensin sodium, Tylosin phosphate | DECCOX, RUMENSIN, TYLOVET 100 | A200-533 | Type B | For the prevention of coccidiosis caused by Eimeria bovis and E. zuernii. for improved feed efficiency, and far reduction in the incidence of liver abscesses caused by Fusobacterium necrophorum and Actinomyces pyogenes in growing-finishing cattle being fed in confinement for slaughter. | VFD (Effective 1/1/17) |
| Decoquinate, Monensin sodium, Tylosin phosphate | DECCOX, RUMENSIN, TYLOVET 100 | A200-533 | Type C | For the prevention of coccidiosis caused by Eimeria bovis and E. zuernii. for improved feed efficiency, and far reduction in the incidence of liver abscesses caused by Fusobacterium necrophorum and Actinomyces pyogenes in growing-finishing cattle being fed in confinement for slaughter. | VFD (Effective 1/1/17) |
| As of 1/1/17, this use is no longer approved | |||||
| Lasalocid | BOVATEC | N096-298 | Type B | For improved feed efficiency and increased rate of weight gain in cattle fed in confinement for slaughter. | OTC |
| Lasalocid | BOVATEC | N096-298 | Type C | For improved feed efficiency and increased rate of weight gain in cattle fed in confinement for slaughter. | OTC |
| Lasalocid | BOVATEC | N096-298 | Type B | For improved feed efficiency in cattle fed in confinement for slaughter | OTC |
| Lasalocid | BOVATEC | N096-298 | Type C | For improved feed efficiency in cattle fed in confinement for slaughter | OTC |
| Lasalocid (Liquid) | BOVATEC | N096-298 | Type B | For improved feed efficiency in cattle fed in confinement for slaughter | OTC |
| Lasalocid (Liquid) | BOVATEC | N096-298 | Type B | For improved feed efficiency and increased rate of weight gain in cattle fed in confinement for slaughter. | OTC |
| Melengestrol acetate | MGA | N039-402 | Type B (liquid) | Heifers Fed in Confinement for Slaughter: For Increased Rate of Weight Gain, Improved Feed Efficiency and Suppression of Estrus (Heat). Heifers Intended for Reproduction: For Suppression of Estrus (Heat). | OTC |
| Melengestrol acetate | MGA | N039-402 | Type C (liquid) | Heifers Fed in Confinement for Slaughter: For Increased Rate of Weight Gain, Improved Feed Efficiency and Suppression of Estrus (Heat). Heifers Intended for Reproduction: For Suppression of Estrus (Heat). | OTC |
| Melengestrol acetate | MGA | N039-402 | Type B | Heifers Fed in Confinement for Slaughter: For Increased Rate of Weight Gain, Improved Feed Efficiency and Suppression of Estrus (Heat). Heifers Intended for Reproduction: For Suppression of Estrus (Heat). | OTC |
| Melengestrol acetate | MGA | N039-402 | Type C | Heifers Fed in Confinement for Slaughter: For Increased Rate of Weight Gain, Improved Feed Efficiency and Suppression of Estrus (Heat). Heifers Intended for Reproduction: For Suppression of Estrus (Heat). | OTC |
+ Melengestrol acetate or Melengestrol acetate (liquid) | ZILMAX, MGA | N141-284 | Type C (component feeding) | Heifers Fed in Confinement for Slaughter: For increased rate of weight gain, improved feed efficiency, and suppression of estrus (heat). MGA: Heifers Fed in Confinement for Slaughter: For increased rate of weight gain, improved feed efficiency, and suppression of estrus (heat). | OTC |
| Zilpaterol + Melengestrol acetate or Melengestrol acetate (liquid) | ZILMAX, MGA | N141-284 | Type C (complete feed) |
For increased rate of weight gain, improved feed efficiency, increased carcass leanness in cattle fed in confinement for slaughter during the last 20 to 40 days on feed. MGA: Heifers Fed in Confinement for Slaughter: For increased rate of weight gain, improved feed efficiency, and suppression of estrus (heat).
| OTC |
| Melengestrol, Ractopamine, Monensin, Tylosin | MGA, OPTAFLEXX, RUMENSIN, TYLAN | N141-233 | Type C | Heifers Fed in Confinement for Slaughter: For increased Rate of Weight Gain, Improved Feed Efficiency and Suppression of Estrus (Heat). | VFD (Effective 1/1/17) |
| Melengestrol, Ractopamine, Monensin, Tylosin (Liquid) | MGA, OPTAFLEXX, RUMENSIN, TYLAN | N141-233 | Type C | Heifers Fed in Confinement for Slaughter: For increased Rate of Weight Gain, Improved Feed Efficiency and Suppression of Estrus (Heat). | VFD (Effective 1/1/17) |
| Melengestrol, Ractopamine, Monensin, Tylosin | MGA, OPTAFLEXX, RUMENSIN, TYLAN | N141-233 | Type C | For increased rate of weight gain, improved feed efficiency, increased carcass leanness, prevention and control of coccidosis due to Eimeria bovis and E. zuernii and reduction of incidence of liver abscesses caused by Fusobacterium necrophorum and Arcanobacterium (Actinomyces) pyogenes in cattle fed in confinement for slaughter for the last 28 to 42 days on feed. | VFD (Effective 1/1/17) |
| Melengestrol, Ractopamine, Monensin, Tylosin | HEIFERMAX, OPTAFLEXX, RUMENSIN, TYLAN | A200-424 | Type C | Heifers Fed in Confinement for Slaughter: For increased Rate of Weight Gain, Improved Feed Efficiency and Suppression of Estrus (Heat). | VFD (Effective 1/1/17) |
| Melengestrol, Ractopamine, Monensin, Tylosin | HEIFERMAX, OPTAFLEXX, RUMENSIN, TYLAN | A200-424 | Type C | Heifers Fed in Confinement for Slaughter: For increased Rate of Weight Gain, Improved Feed Efficiency and Suppression of Estrus (Heat). | VFD (Effective 1/1/17) |
| Melengestrol, Ractopamine, Monensin, Tylosin | HEIFERMAX, OPTAFLEXX, RUMENSIN, TYLAN | A200-424 | Type C | For increased rate of weight gain, improved feed efficiency, prevention and control of coccidosis due to Eimeria bovis and E. zuernii and reduction of incidence of liver abscesses caused by Fusobacterium necrophorum and Arcanobacterium (Actinomyces) pyogenes in cattle fed in confinement for slaughter for the last 28 to 42 days on feed. | VFD (Effective 1/1/17) |
| Melengestrol (Liquid), Ractopamine, Monensin, Tylosin | ACTOGAIN, RUMENSIN, TYLAN, MGA | A200-562 | Type C | Heifers Fed in Confinement for Slaughter: For increased Rate of Weight Gain, Improved Feed Efficiency and Suppression of Estrus (Heat). | VFD (Effective 1/1/17) |
| Melengestrol, Ractopamine, Monensin, Tylosin | ACTOGAIN, RUMENSIN, TYLAN, MGA | A200-562 | Type C | Heifers Fed in Confinement for Slaughter: For increased Rate of Weight Gain, Improved Feed Efficiency and Suppression of Estrus (Heat). | VFD (Effective 1/1/17) |
| Melengestrol, Ractopamine, Monensin, Tylosin | ACTOGAIN, RUMENSIN, TYLAN, MGA | A200-562 | Type C | For increased rate of weight gain, improved feed efficiency, increased carcass leanness, prevention and control of coccidosis due to Eimeria bovis and E. zuernii and reduction of incidence of liver abscesses caused by Fusobacterium necrophorum and Arcanobacterium (Actinomyces) pyogenes in cattle fed in confinement for slaughter for the last 28 to 42 days on feed. | VFD (Effective 1/1/17) |
| Melengestrol, Lasalocid, Tylosin | HEIFERMAX, BOVATEC, TYLAN | A200-430 | Type C | For increased rate of weight gain, improved feed efficiency, and suppression of estrus (heat) in heifers being fed in confinement for slaughter. | VFD (Effective 1/1/17) |
| Melengestrol, Lasalocid, Tylosin | HEIFERMAX, BOVATEC, TYLAN | A200-430 | Type C | For increased rate of weight gain, improved feed efficiency, and suppression of estrus (heat), and for reduction of incidence of liver abscesses associated with Fusobacterium necrophorum and Arcanobacterium pyogenes in heifers fed in confinement for slaughter. | VFD (Effective 1/1/17) |
| Melengestrol + Lasalocid and Tylosin | MGA, BOVATEC, TYLOVET | A200-535 | Type C | For increased rate of weight gain, improved feed efficiency, and suppression of estrus (heat) in heifers being fed in confinement for slaughter. | VFD (Effective 1/1/17) |
| Melengestrol, Lasalocid, Tylosin | MGA, BOVATEC, TYLOVET | A200-535 | Type C | For increased rate of weight gain, improved feed efficiency, and suppression of estrus (heat), and for reduction of incidence of liver abscesses associated with Fusobacterium necrophorum and Arcanobacterium pyogenes in heifers fed in confinement for slaughter. | VFD (Effective 1/1/17) |
| Melengestrol, Tylosin (Liquid) | MGA, TYLAN | N138-995 | Type C | Heifers being fed in confinement for slaughter: For increased rate of weight gain, improved feed efficiency, suppression of estrus (heat), and for reduction of incidence of liver abscesses associated with Fusobacterium necrophorum and Arcanobacterium pyogenes. | VFD (Effective 1/1/17) |
| Melengestrol, Tylosin | MGA, TYLAN | N138-995 | Type C | Heifers being fed in confinement for slaughter: For increased rate of weight gain, improved feed efficiency, suppression of estrus (heat), and for reduction of incidence of liver abscesses associated with Fusobacterium necrophorum and Arcanobacterium pyogenes. | VFD (Effective 1/1/17) |
| Melengestrol, Tylosin | HEIFERMAX, TYLAN | A200-427 | Type C | Heifers being fed in confinement for slaughter: For increased rate of weight gain, improved feed efficiency, suppression of estrus (heat), and for reduction of incidence of liver abscesses associated with Fusobacterium necrophorum and Arcanobacterium pyogenes. | VFD (Effective 1/1/17) |
| Melengestrol, Tylosin | HEIFERMAX, TYLAN | A200-427 | Type C | Heifers being fed in confinement for slaughter: For increased rate of weight gain, improved feed efficiency, suppression of estrus (heat), and for reduction of incidence of liver abscesses associated with Fusobacterium necrophorum and Arcanobacterium pyogenes. | VFD (Effective 1/1/17) |
| Melengestrol, Monensin, Tylosin | HEIFERMAX, RUMENSIN, TYLAN | A200-375 | Type C | Increased rate of weight gain, improved feed efficiency, suppression of estrus (heat), prevention and control of coccidiosis due to Eimeria bovis and Eimeria zuernii, reduction of incidence of liver abscesses caused by Fusobacterium necrophorum and Arcanobacterium pyogenes in heifers fed in confinement for slaughter. | VFD (Effective 1/1/17) |
| Melengestrol, Monensin, Tylosin | HEIFERMAX, RUMENSIN, TYLAN | A200-375 | Type C | Increased rate of weight gain, improved feed efficiency, suppression of estrus (heat), prevention and control of coccidiosis due to Eimeria bovis and Eimeria zuernii, reduction of incidence of liver abscesses caused by Fusobacterium necrophorum and Arcanobacterium pyogenes in heifers fed in confinement for slaughter. | VFD (Effective 1/1/17) |
| Monensin | MONENSIN | N095-735 | Type B | For prevention and control of coccidiosis due to Eimeria bovis and Eimeria zuernii, improved feed efficiency. | OTC |
| Monensin | MONENSIN | N095-735 | Type C | For prevention and control of coccidiosis due to Eimeria bovis and Eimeria zuernii. | OTC |
| Monensin | MONENSIN | N095-735 | Type C | For improved feed efficiency. | OTC |
| Monensin (Liquid) | MONENSIN | N095-735 | Type B | For improved feed efficiency. | OTC |
| Monensin and Tylosin Phosphate (Liquid) | RUMENSIN AND TYLAN | N104-646 | Type B | For prevention and control of coccidiosis due to Eimeria bovis and E. zuernii and reduction of incidence of liver abscesses caused by Fusobacterium necrophorum and Arcanobacterium (Actinomyces) pyogenes. | VFD (Effective 1/1/17) |
| Monensin and Tylosin Phosphate | RUMENSIN AND TYLAN | N104-646 | Type B | For improved feed efficiency and reduction of incidence of liver abscesses caused by Fusobacterium necrophorum and Arcanobacterium (Actinomyces) pyogenes. | VFD (Effective 1/1/17) |
| Monensin and Tylosin Phosphate | RUMENSIN AND TYLAN | N104-646 | Type C | For prevention and control of coccidiosis due to Eimeria bovis and E. zuernii and reduction of incidence of liver abscesses caused by Fusobacterium necrophorum and Arcanobacterium (Actinomyces) pyogenes. | VFD (Effective 1/1/17) |
| Monensin and Tylosin Phosphate | RUMENSIN AND TYLAN | N104-646 | Type C | For improved feed efficiency and reduction of incidence of liver abscesses caused by Fusobacterium necrophorum and Arcanobacterium (Actinomyces) pyogenes. | VFD (Effective 1/1/17) |
| Monensin and Tylosin Phosphate | RUMENSIN AND TYLAN | N104-646 | Type B | For prevention and control of coccidiosis due to Eimeria bovis and E. zuernii and reduction of incidence of liver abscesses caused by Fusobacterium necrophorum and Arcanobacterium (Actinomyces) pyogenes... | VFD (Effective 1/1/17) |
| Monensin and Tylosin Phosphate (Liquid) | RUMENSIN AND TYLAN | N104-646 | Type B | For improved feed efficiency and reduction of incidence of liver abscesses caused by Fusobacterium necrophorum and Arcanobacterium (Actinomyces) pyogenes... | VFD (Effective 1/1/17) |
| Monensin and Tylosin Phosphate (Liquid) | RUMENSIN AND TYLOVET 100 | A200-531 | Type B | For prevention and control of coccidiosis due to Eimeria bovis and E. zuernii and reduction of incidence of liver abscesses caused by Fusobacterium necropliorum and Arcanobacterium (Actinomyces) pyogenes in cattle fed in confinement for slaughter. | VFD (Effective 1/1/17) |
| Monensin and Tylosin (Liquid) | RUMENSIN AND TYLOVET 100 | A200-531 | Type B | For improved feed efficiency and reduction of incidence of liver abscesses caused by Fusobacterium necrophorum and Arcanobacterium (Actinomyces) pyogenes in cattle fed in confinement for slaughter. | VFD (Effective 1/1/17) |
| Monensin and Tylosin | RUMENSIN AND TYLOVET 100 | A200-531 | Type B | For prevention and control of coccidosis due to Eimeria bovis and E. zuernii and reduction of incidence of liver abscesses caused by Fusobacterium necrophorum and Arcanobactenum (Actinomyces) pyogenes in cattle fed in confinement for slaughter. | VFD (Effective 1/1/17) |
| Monensin and Tylosin | RUMENSIN AND TYLOVET 100 | A200-531 | Type B | For improved feed efficiency and reduction of incidence of liver abscesses caused by Fusobacterium necrophorum and Arcanobacterium (Actinomyces) pyogenes in cattle fed in confinement for slaughter. | VFD (Effective 1/1/17) |
| Monensin and Tylosin | RUMENSIN AND TYLOVET 100 | A200-531 | Type C | For prevention and control of coccidiosis due to Eimeria bovis and E. zuernii and reduction of incidence of liver abscesses caused by Fusobacterium necrophorum and Arcanobacterium (Actinomyces) pyogenes in cattle fed in confinement for slaughter | VFD (Effective 1/1/17) |
| Monensin and Tylosin | RUMENSIN AND TYLOVET 100 | A200-531 | Type C | For improved feed efficiency and reduction of incidence of liver abscesses caused by Fusobactenum necrophorum and Arcanobacterium (Actinomyces) pyogenes in cattle fed in confinement for slaughter. | VFD (Effective 1/1/17) |
Ractopamine (top-dress) + Monensin and Tylosin | RUMENSIN, TYLOVET 100, ACTOGAIN 45 | A200-585 | Type C | Actogain: For increased rate of weight gain and improved feed efficiency in cattle fed in confinement for slaughter during the last 28 to 42 days on feed. | VFD (Effective 1/1/17) |
| Ractopamine | OPTAFLEXX 45 | N141-221 | Type B | For increased rate of weight gain, improved feed efficiency and increased carcass leanness... | OTC |
| Ractopamine | OPTAFLEXX 45 | N141-221 | Type B | For increased rate of weight gain and improved feed efficiency... | OTC |
| Ractopamine | OPTAFLEXX 45 | N141-221 | Type C | For increased rate of weight gain and improved feed efficiency... | OTC |
| Ractopamine | OPTAFLEXX 45 | N141-221 | Type C | For increased rate of weight gain, improved feed efficiency, and increased carcass leanness... | OTC |
| Ractopamine | OPTAFLEXX 45 | N141-221 | Type C | For increased rate of weight gain and improved feed efficiency... | OTC |
| Ractopamine (Liquid) | OPTAFLEXX 45 | N141-221 | Type B | For increased rate of weight gain, improved feed efficiency and increased carcass leanness... | OTC |
| Ractopamine (Liquid) | OPTAFLEXX 45 | N141-221 | Type B | For increased rate of weight gain and improved feed efficiency... | OTC |
| Ractopamine (Liquid for Top-Dress) | ACTOGAIN 45 | A200-548 | Type B | For increased rate of weight gain and improved feed efficiency in cattle fed in confinement for slaughter during the last 28 to 42 days on feed. | OTC |
| Ractopamine | ACTOGAIN 45 | A200-548 | Type B | For increased rate of weight gain and improved feed efficiency in cattle fed in confinement for slaughter during the last 28 to 42 days on feed. | OTC |
| Ractopamine | ACTOGAIN 45 | A200-548 | Type C | For increased rate of weight gain and improved feed efficiency in cattle fed in confinement for slaughter during the last 28 to 42 days on feed. | OTC |
| Ractopamine (Liquid) | ACTOGAIN 45 | A200-548 | Type B | For increased rate of weight gain, improved feed efficiency and increased carcass leanness in cattle fed in confinement for slaughter during the last 28 to 42 days on feed. | OTC |
| Ractopamine | ACTOGAIN 45 | A200-548 | Type B | For increased rate of weight gain and improved feed efficiency, and for increased rate of weight gain, improved feed efficiency, and increased carcass leanness in cattle fed in confinement for slaughter during the last 28 to 42 days on feed. | OTC |
| Ractopamine | ACTOGAIN 45 | A200-548 | Type C | For increased rate of weight gain and improved feed efficiency in cattle fed in confinement for slaughter during the last 28 to 42 days on feed. | OTC |
| Ractopamine | ACTOGAIN 45 | A200-548 | Type C | For increased rate of weight gain and improved feed efficiency in cattle fed in confinement for slaughter during the last 28 to 42 days on feed. | OTC |
| Ractopamine and Monensin Plus | OPTAFLEXX AND RUMENSIN | N141-225 | Type C | For increased rate of weight gain, improved feed efficiency and increased carcass leanness, and control of coccidiosis due to Eimeria bovis and E. zuernii... | OTC |
| Ractopamine and Monensin Plus | OPTAFLEXX AND RUMENSIN | N141-225 | Type B | For increased rate of weight gain, improved feed efficiency and increased carcass leanness, and control of coccidiosis due to Eimeria bovis and E. zuernii... | OTC |
| Ractopamine and Monensin | OPTAFLEXX AND RUMENSIN | N141-225 | Type C | For increased rate of weight gain, improved feed efficiency, and control of coccidiosis due to Eimeria bovis and E. zuernii... | OTC |
| Ractopamine and Monensin | OPTAFLEXX AND RUMENSIN | N141-225 | Type B | For increased rate of weight gain, improved feed efficiency, and control of coccidiosis due to Eimeria bovis and E. zuernii... | OTC |
| Ractopamine and Monensin (Liquid) | OPTAFLEXX AND RUMENSIN | N141-225 | Type B | For increased rate of weight gain, improved feed efficiency, and control of coccidiosis due to Eimeria bovis and E. zuernii... | OTC |
+ | HEIFERMAX, MONENSIN AND RACTOPAMINE | A200-448 | Type C | For increased rate of weight gain, improved feed efficiency, increased carcass leanness, prevention and control of coccidiosis due to Eimeria bovis and E. zuernii... Heifermax: For Beef and Dairy Heifers...For increased weight gain, improved feed efficiency, and suppression of estrus (heat). | OTC |
+ | Actogain 45, Rumensin, MGA | A200-560 | Type C | For increased rate of weight gain, improved feed efficiency, increased carcass leanness and prevention and control of coccidiosis due to Eimeria bovis and E. zuernii in cattle fed in confinement for slaughter during the last 28 to 42 days on feed. MGA: Heifers Fed in Confinement for Slaughter: For lncreased Rate of Weight Gain, lmproved Feed | OTC |
| Ractopamine, Monensin, Tylosin | OPTAFLEXX, RUMENSIN, TYLOVET | A200-566 | Type B | For increased rate of weight gain, improved feed efficiency, increased carcass leanness, prevention and control of coccidiosis due to Eimeria bovis and E. zuernii and reduction of incidence of liver abscesses caused by Fusobacterium necrophorum and Arcanobacterium (Actinomyces) pyogenes in cattle fed in confinement for slaughter during the last 28 to 42 days on feed. | VFD (Effective 1/1/17) |
| Ractopamine, Monensin, Tylosin | OPTAFLEXX, RUMENSIN, TYLOVET | A200-566 | Type B | For increased rate of weight gain, improved feed efficiency, increased carcass leanness, prevention and control of coccidiosis due to Eimeria bovis and E. zuemii and reduction of incidence of liver abscesses caused by Fusobacterium necrophorum and Arcanobacterium (Actinomyces) pyogenes in cattle fed in confinement for slaughter during the last 28 to 42 days on feed. | VFD (Effective 1/1/17) |
| Ractopamine, Monensin, Tylosin | OPTAFLEXX, RUMENSIN, TYLOVET | A200-566 | Type C | For increased rate of weight gain, improved feed efficiency, increased carcass leanness, prevention and control of coccidiosis due to Eimeria bovis and E. zuemii and reduction of incidence of liver abscesses caused by Fusobacterium necrophorum and Arcanobacterium (Actinomyces) pyogenes in cattle fed in confinement for slaughter during the last 28 to 42 days on feed. | VFD (Effective 1/1/17) |
| Ractopamine, Monensin, Tylosin (liquid) | OPTAFLEXX, RUMENSIN, TYLOVET | A200-566 | Type B | For increased rate of weight gain, improved feed efficiency, prevention and control of coccidiosis due to Eimeria bovis and E. zuernii and reduction of incidence of liver abscesses caused by Fusobacterium necrophorum and Arcanobacterium (Actinomyces) pyogenes in cattle fed in confinement for slaughter during the last 28 to 42 days on feed. | VFD (Effective 1/1/17) |
| Ractopamine, Monensin, Tylosin | OPTAFLEXX, RUMENSIN, TYLOVET | A200-566 | Type B | For increased rate of weight gain, improved feed efficiency, prevention and control of coccidiosis due to Eimeria bovis and E. zuernii and reduction of incidence of liver abscesses caused by Fusobacterium necrophorum and Arcanobacterium (Actinomyces) pyogenes in cattle fed in confinement for slaughter during the last 28 to 42 days on feed. | VFD (Effective 1/1/17) |
| Ractopamine, Monensin, Tylosin | OPTAFLEXX, RUMENSIN, TYLOVET | A200-566 | Type C | For increased rate of weight gain, improved feed efficiency, prevention and control of coccidiosis due to Eimeria bovis and E. zuernii and reduction of incidence of liver abscesses caused by Fusobacterium necrophorum and Arcanobacterium (Actinomyces) pyogenes in cattle fed in confinement for slaughter during the last 28 to 42 days on feed. | VFD (Effective 1/1/17) |
+ Monensin, Tylosin | OPTAFLEXX, RUMENSIN, TYLOVET | A200-566 | Type C | For increased rate of weight gain and improved feed efficiency in cattle fed in confinement for slaughter during the last 28 to 42 days on feed. | VFD (Effective 1/1/17) |
Melengestrol acetate or Liquid Melengestrol acetate + Monensin and Tylosin | ACTOGAIN 45, RUMENSIN, TYLOVET 100, MGA | A200-583 | Type C | For increased rate of weight gain, improved feed efficiency, increased carcass leanness, prevention and control of coccidosis due to Eimeria bovis and E. zuernii and reduction of incidence of liver abscesses caused by Fusobacterium necrophorum and Arcanobacterium (Actinomyces) pyogenes in cattle fed in confinement for slaughter for the last 28 to 42 days on feed. MGA: Heifers Fed in Confinement for Slaughter: For increased Rate of Weight Gain, Improved Feed Efficiency and Suppression of Estrus (Heat). | VFD (Effective 1/1/17) |
| Ractopamine, Monensin and Tylosin (Liquid) | OPTAFLEXX, RUMENSIN AND TYLAN | N141-224 | Type B | For increased rate of weight gain, improved feed efficiency, increased carcass leanness, prevention and control of coccidiosis due to Eimeria bovis and E. zuernii and reduction of incidence of liver abscesses caused by Fusobacterium necrophorum and Arcanobacterium (Actinomyces) pyogenes in cattle fed in confinement for slaughter during the last 28 to 42 days on feed. | VFD (Effective 1/1/17) |
| Ractopamine, Monensin and Tylosin (Liquid) | OPTAFLEXX, RUMENSIN AND TYLAN | N141-224 | Type B | For increased rate of weight gain, improved feed efficiency, prevention and control of coccidiosis due to Eimeria bovis and E. zuernii and reduction of incidence of liver abscesses caused by Fusobacterium necrophorum and Arcanobacterium (Actinomyces) pyogenes in cattle fed in confinement for slaughter during the last 28 to 42 days on feed | VFD (Effective 1/1/17) |
| Ractopamine, Monensin and Tylosin | OPTAFLEXX, RUMENSIN AND TYLAN | N141-224 | Type B | For increased rate of weight gain, improved feed efficiency, prevention and control of coccidosis due to Eimeria bovis and E. zuernii and reduction of incidence of liver abscesses caused by Fusobacterium necrophorum and Arcanobacterium (Actinomyces) pyogenes in cattle fed in confinement for slaughter during the last 28 to 42 days on feed. | VFD (Effective 1/1/17) |
| Ractopamine, Monensin and Tylosin | OPTAFLEXX, RUMENSIN AND TYLAN | N141-224 | Type C | For increased rate of weight gain, improved feed efficiency, prevention and control of coccidosis due to Eimeria bovis and E. zuernii and reduction of incidence of liver abscesses caused by Fusobacterium necrophorum and Arcanobacterium (Actinomyces) pyogenes in cattle fed in confinement for slaughter during the last 28 to 42 days on feed. | VFD (Effective 1/1/17) |
| Ractopamine, Monensin and Tylosin | OPTAFLEXX, RUMENSIN AND TYLAN | N141-224 | Type B | For increased rate of weight gain, improved feed efficiency, increased carcass leanness, prevention and control of coccidosis due to Eimeria bovis and E. zuernii and reduction of incidence of liver abscesses caused by Fusobacterium necrophorum and Arcanobacterium (Actinomyces) pyogenes in cattle fed in confinement for slaughter during the last 28 to 42 days on feed. | VFD (Effective 1/1/17) |
| Ractopamine, Monensin and Tylosin | OPTAFLEXX, RUMENSIN AND TYLAN | N141-224 | Type C | For increased rate of weight gain, improved feed efficiency, increased carcass leanness, prevention and control of coccidosis due to Eimeria bovis and E. zuernii and reduction of incidence of liver abscesses caused by Fusobacterium necrophorum and Arcanobacterium (Actinomyces) pyogenes in cattle fed in confinement for slaughter during the last 28 to 42 days on feed. | VFD (Effective 1/1/17) |
| Ractopamine, Monensin and Tylosin | OPTAFLEXX, RUMENSIN AND TYLAN | N141-224 | Type C | For increased rate of weight gain and improved feed efficiency in cattle fed in confinement for slaughter during the last 28 to 42 days on feed. | VFD (Effective 1/1/17) |
| Ractopamine, Monensin and Tylosin | ACTOGAIN 45, RUMENSIN, TYLAN | A200-561 | Type B (liquid) | For increased rate of weight gain, improved feed efficiency, prevention and control of coccidiosis due to Eimeria bovis and E. zuernii and reduction of incidence of liver abscesses caused by Fusobacterium necrophorum and Arcanobacterium (Actinomyces) pyogenes in cattle fed in confinement for slaughter during the last 28 to 42 days on feed. | VFD (Effective 1/1/17) |
| Ractopamine, Monensin and Tylosin | ACTOGAIN 45, RUMENSIN, TYLAN | A200-561 | Type B | For increased rate of weight gain, improved feed efficiency, prevention and control of coccidiosis due to Eimeria bovis and E. zuernii and reduction of incidence of liver abscesses caused by Fusobacterium necrophorum and Arcanobacterium (Actinomyces) pyogenes in cattle fed in confinement for slaughter during the last 28 to 42 days on feed. | VFD (Effective 1/1/17) |
| Ractopamine, Monensin and Tylosin | ACTOGAIN 45, RUMENSIN, TYLAN | A200-561 | Type B (liquid) | For increased rate of weight gain, improved feed efficiency, increased carcass leanness, prevention and control of coccidiosis due to Eimeria bovis and E. zuernii and reduction of incidence of liver abscesses caused by Fusobacterium necrophorum and Arcanobacterium (Actinomyces) pyogenes in cattle fed in confinement for slaughter during the last 28 to 42 days on feed. | VFD (Effective 1/1/17) |
+ Monensin and Tylosin | ACTOGAIN 45, RUMENSIN, TYLAN | A200-561 | Type C (top-dress) | For increased rate of weight gain and improved feed efficiency in cattle fed in confinement for slaughter during the last 28 to 42 days on feed. | VFD (Effective 1/1/17) |
| Ractopamine, Monensin and Tylosin | ACTOGAIN 45, RUMENSIN, TYLAN | A200-561 | Type B | For increased rate of weight gain, improved feed efficiency, increased carcass leanness, prevention and control of coccidiosis due to Eimeria bovis and E. zuernii and reduction of incidence of liver abscesses caused by Fusobacterium necrophorum and Arcanobacterium (Actinomyces) pyogenes in cattle fed in confinement for slaughter during the last 28 to 42 days on feed. | VFD (Effective 1/1/17) |
| Ractopamine, Monensin and Tylosin | ACTOGAIN 45, RUMENSIN, TYLAN | A200-561 | Type C | For increased rate of weight gain, improved feed efficiency, prevention and control of coccidiosis due to Eimeria bovis and E. zuernii and reduction of incidence of liver abscesses caused by Fusobacterium necrophorum and Arcanobacterium (Actinomyces) pyogenes in cattle fed in confinement for slaughter for the last 28 to 42 days on feed. | VFD (Effective 1/1/17) |
| Ractopamine, Monensin and Tylosin | ACTOGAIN 45, RUMENSIN, TYLAN | A200-561 | Type C | For increased rate of weight gain, improved feed efficiency, increased carcass leanness, prevention and control of coccidiosis due to Eimeria bovis and E. zuernii and reduction of incidence of liver abscesses caused by Fusobacterium necrophorum and Arcanobacterium (Actinomyces) pyogenes in cattle fed in confinement for slaughter for the last 28 to 42 days on feed. | VFD (Effective 1/1/17) |
| Ractopamine, Monensin and Tylosin | ACTOGAIN 45, RUMENSIN, TYLOVET 100 | A200-585 | Type B | For increased rate of weight gain, improved feed efficiency, prevention and control of coccidiosis due to Eimeria bovis and E. zuernii and reduction of incidence of liver abscesses caused by Fusobacterium necrophorum and Arcanobacterium (Actinomyces) pyogenes in cattle fed in confinement for slaughter during the last 28 to 42 days on feed. | VFD (Effective 1/1/17) |
| Ractopamine, Monensin and Tylosin Plus | ACTOGAIN 45, RUMENSIN, TYLOVET 100 | A200-585 | Type B | For increased rate of weight gain, improved feed efficiency, increased carcass leanness, prevention and control of coccidiosis due to Eimeria bovis and E. zuernii and reduction of incidence of liver abscesses caused by Fusobacterium necrophorum and Arcanobacterium (Actinomyces) pyogenes in cattle fed in confinement for slaughter during the last 28 to 42 days on feed. | VFD (Effective 1/1/17) |
| Ractopamine, Monensin and Tylosin | ACTOGAIN 45, RUMENSIN, TYLOVET 100 | A200-585 | Type B (carcass leanness) | For increased rate of weight gain, improved feed efficiency, increased carcass leanness, prevention and control of coccidiosis due to Eimeria bovis and E. zuernii and reduction of incidence of liver abscesses caused by Fusobacterium necrophorum and Arcanobacterium (Actinomyces) pyogenes in cattle fed in confinement for slaughter during the last 28 to 42 days on feed. | VFD (Effective 1/1/17) |
| Ractopamine, Monensin and Tylosin | ACTOGAIN 45, RUMENSIN, TYLOVET 100 | A200-585 | Type B (liquid) | For increased rate of weight gain, improved feed efficiency, prevention and control of coccidiosis due to Eimeria bovis and E. zuernii and reduction of incidence of liver abscesses caused by Fusobacterium necrophorum and Arcanobacterium (Actinomyces) pyogenes in cattle fed in confinement for slaughter during the last 28 to 42 days on feed. | VFD (Effective 1/1/17) |
| Ractopamine, Monensin and Tylosin | ACTOGAIN 45, RUMENSIN, TYLOVET 100 | A200-585 | Type C | For increased rate of weight gain, improved feed efficiency, prevention and control of coccidiosis due to Eimeria bovis and E. zuernii and reduction of incidence of liver abscesses caused by Fusobacterium necrophorum and Arcanobacterium (Actinomyces) pyogenes in cattle fed in confinement for slaughter for the last 28 to 42 days on feed. | VFD (Effective 1/1/17) |
| Ractopamine, Monensin and Tylosin Plus | ACTOGAIN 45, RUMENSIN, TYLOVET 100 | A200-585 | Type C | For increased rate of weight gain, improved feed efficiency, increased carcass leanness, prevention and control of coccidiosis due to Eimeria bovis and E. zuernii and reduction of incidence of liver abscesses caused by Fusobacterium necrophorum and Arcanobacterium (Actinomyces) pyogenes in cattle fed in confinement for slaughter for the last 28 to 42 days on feed. | VFD (Effective 1/1/17) |
| Tilmicosin and Monensin | RUMENSIN AND PULMOTIL | N141-343 | Type B | For prevention and control of coccidiosis due to Eimeria bovis and Eimeria zuernii and control of bovine respiratory disease (BRD) associated with Mannheimia haemolytica, Pasteurella multocida, and Histophilus somni in groups of cattle fed in confinement for slaughter, where active BRD has been diagnosed in at least 10% of the animals in the group. | VFD |
| Tilmicosin and Monensin | RUMENSIN AND PULMOTIL | N141-343 | Type C | For prevention and control of coccidiosis due to Eimeria bovis and Eimeria zuernii and control of bovine respiratory disease (BRD) associated with Mannheimia haemolytica, Pasteurella multocida, and Histophilus somni in groups of cattle fed in confinement for slaughter, where active BRD has been diagnosed in at least 10% of the animals in the group. | VFD |
| Tilmicosin and Monensin | RUMENSIN AND PULMOTIL | N141-343 | Type B | For improved feed efficiency and control of bovine respiratory disease (BRD) associated with Mannheimia haemolytica, Pasteurella multocida, and Histophilus somni in groups of cattle fed in confinement for slaughter, where active BRD has been diagnosed in at least 10% of the animals in the group. | VFD |
| Tilmicosin and Monensin | RUMENSIN AND PULMOTIL | N141-343 | Type C | For improved feed efficiency and control of bovine respiratory disease (BRD) associated with Mannheimia haemolytica, Pasteurella multocida, and Histophilus somni in groups of cattle fed in confinement for slaughter, where active BRD has been diagnosed in at least 10% of the animals in the group. | VFD |
| Tilmicosin and Monensin | TILMOVET AND RUMENSIN | A200-596 | Type B | For prevention and control of coccidlosis due to Eimeria bovis and Eimeria zuernii and control of bovine respiratory disease (BRD) associated with Mannheimia haemolytica, Pasteurella multocida, and Histophilus somni in groups of cattle fed in confinement for slaughter, where active BRD has been diagnosed in at least 10% of the animals in the group. | VFD |
| Tilmicosin and Monensin | TILMOVET AND RUMENSIN | A200-596 | Type B | For improved feed efficiency and control of bovine respiratory disease (BRD) associated with Mannheimia haemolytica, Pasteurella multocida, and Histophilus somni in groups of cattle fed in confinement for slaughter, where active BRD has been diagnosed in at least 10% of the animals in the group. | VFD |
| Tilmicosin and Monensin | TILMOVET AND RUMENSIN | A200-596 | Type C | For prevention and control of coccidlosis due to Eimeria bovis and Eimeria zuernii and control of bovine respiratory disease (BRD) associated with Mannheimia haemolytica, Pasteurella multocida, and Histophilus somni in groups of cattle fed in confinement for slaughter, where active BRD has been diagnosed in at least 10% of the animals in the group. | VFD |
| Tilmicosin and Monensin | TILMOVET AND RUMENSIN | A200-596 | Type C | For improved feed efficiency and control of bovine respiratory disease (BRD) associated with Mannheimia haemolytica, Pasteurella multocida, and Histophilus somni in groups of cattle fed in confinement for slaughter, where active BRD has been diagnosed in at least 10% of the animals in the group. | VFD |
| Zilpaterol, Monensin, Tylosin | ZILMAX, RUMENSIN AND TYLAN | N141-276 | Type B | For increased rate of weight gain, improved feed efficiency, increased carcass leanness, prevention and control of coccidiosis due to Eimeria bovis and E. zuernii, and reduction of incidence of incidence of liver abscesses caused by Fusobacterium necrophorum and Arcanobacterium (Actinomyces) pyogenes in cattle fed in confinement for slaughter for the last 20 to 40 days on feed. | VFD (Effective 1/1/17) |
| Zilpaterol, Monensin, Tylosin | ZILMAX, RUMENSIN AND TYLAN | N141-276 | Type C | For increased rate of weight gain, improved feed efficiency, increased carcass leanness, prevention and control of coccidiosis due to Eimeria bovis and E. zuernii, and reduction of incidence of incidence of liver abscesses caused by Fusobacterium necrophorum and Arcanobacterium (Actinomyces) pyogenes in cattle fed in confinement for slaughter for the last 20 to 40 days on feed. | VFD (Effective 1/1/17) |
| Zilpaterol, Monensin, Tylosin | ZILMAX, RUMENSIN AND TYLAN | N141-276 | Type B (component) | For increased rate of weight gain, improved feed efficiency, increased carcass leanness, prevention and control of coccidiosis due to Eimeria bovis and E. zuernii, and reduction of incidence of incidence of liver abscesses caused by Fusobacterium necrophorum and Arcanobacterium (Actinomyces) pyogenes in cattle fed in confinement for slaughter for the last 20 to 40 days on feed. | VFD (Effective 1/1/17) |
| Zilpaterol, Monensin, Tylosin | ZILMAX, RUMENSIN AND TYLAN | N141-276 | Type C (component) | For increased rate of weight gain, improved feed efficiency, increased carcass leanness, prevention and control of coccidiosis due to Eimeria bovis and E. zuernii, and reduction of incidence of incidence of liver abscesses caused by Fusobacterium necrophorum and Arcanobacterium (Actinomyces) pyogenes in cattle fed in confinement for slaughter for the last 20 to 40 days on feed. | VFD (Effective 1/1/17) |
| Zilpaterol, Monensin, Tylosin | ZILMAX, RUMENSIN AND TYLAN | N141-276 | Type B (liquid) | For increased rate of weight gain, improved feed efficiency, increased carcass leanness, prevention and control of coccidiosis due to Eimeria bovis and E. zuernii, and reduction of incidence of liver abscesses caused by Fusobacterium necrophorum and Arcanobacterium (Actinomyces) pyogenes in cattle fed in confinement for slaughter for the last 20 to 40 days on feed. | VFD (Effective 1/1/17) |
| Zilpaterol, Monensin, Tylosin | ZILMAX, RUMENSIN AND TYLAN | N141-276 | Type B (liquid - component feeding) | For increased rate of weight gain, improved feed efficiency, increased carcass leanness, prevention and control of coccidiosis due to Eimeria bovis and E. zuernii, and reduction of incidence of liver abscesses caused by Fusobacterium necrophorum and Arcanobacterium (Actinomyces) pyogenes in cattle fed in confinement for slaughter for the last 20 to 40 days on feed. | VFD (Effective 1/1/17) |
| Zilpaterol, Monensin, Tylosin (liquid) | ZILMAX, RUMENSIN, TYLOVET | A200-547 | Type B | For increased rate of weight gain, improved feed efficiency, increased carcass leanness, prevention and control of coccidiosis due to Eimeria bovis and E. zuernii, and reduction of incidence of liver abscesses caused by Fusobacterium necrophorum and Arcanobacterium (Actinomyces) pyogenes in cattle fed in confinement for slaughter for the last 20 to 40 days on feed. | VFD (Effective 1/1/17) |
| Zilpaterol, Monensin, Tylosin | ZILMAX, RUMENSIN, TYLOVET | A200-547 | Type B | For increased rate of weight gain, improved feed efficiency, increased carcass leanness, prevention and control of coccidiosis due to Eimeria bovis and E. zuernii, and reduction of incidence of liver abscesses caused by Fusobacterium necrophorum and Arcanobacterium (Actinomyces) pyogenes in cattle fed in confinement for slaughter for the last 20 to 40 days on feed. | VFD (Effective 1/1/17) |
| Zilpaterol, Monensin, Tylosin | ZILMAX, RUMENSIN, TYLOVET | A200-547 | Type C | For increased rate of weight gain, improved feed efficiency, increased carcass leanness, prevention and control of coccidiosis due to Eimeria bovis and E. zuernii, and reduction of incidence of liver abscesses caused by Fusobacterium necrophorum and Arcanobacterium (Actinomyces) pyogenes in cattle fed in confinement for slaughter for the last 20 to 40 days on feed. | VFD (Effective 1/1/17) |
| Zilpaterol, Monensin | ZILMAX AND RUMENSIN | N141-278 | Type B (liquid - component feeding) | For increased rate of weight gain, improved feed efficiency, increased carcass leanness, and prevention and control of coccidiosis due to Eimeria bovis and E. zuernii in cattle fed in confinement for slaughter for the last 20 to 40 days on feed. | OTC |
| Zilpaterol, Monensin | ZILMAX AND RUMENSIN | N141-278 | Type B (component feeding) | For increased rate of weight gain, improved feed efficiency, increased carcass leanness, and prevention and control of coccidiosis due to Eimeria bovis and E. zuernii in cattle fed in confinement for slaughter for the last 20 to 40 days on feed. | OTC |
| Zilpaterol, Monensin | ZILMAX AND RUMENSIN | N141-278 | Type B (liquid) | For increased rate of weight gain, improved feed efficiency, increased carcass leanness, and prevention and control of coccidiosis due to Eimeria bovis and E. zuernii in cattle fed in confinement for slaughter for the last 20 to 40 days on feed. | OTC |
| Zilpaterol, Monensin | ZILMAX AND RUMENSIN | N141-278 | Type B | For increased rate of weight gain, improved feed efficiency, increased carcass leanness, and prevention and control of coccidiosis due to Eimeria bovis and E. zuernii in cattle fed in confinement for slaughter for the last 20 to 40 days on feed. | OTC |
| Zilpaterol, Monensin | ZILMAX AND RUMENSIN | N141-278 | Type C (component) | For increased rate of weight gain, improved feed efficiency, increased carcass leanness, and prevention and control of coccidiosis due to Eimeria bovis and E. zuernii in cattle fed in confinement for slaughter for the last 20 to 40 days on feed. | OTC |
| Zilpaterol, Monensin | ZILMAX AND RUMENSIN | N141-278 | Type C | For increased rate of weight gain, improved feed efficiency, increased carcass leanness, and prevention and control of coccidiosis due to Eimeria bovis and E. zuernii in cattle fed in confinement for slaughter for the last 20 to 40 days on feed. | OTC |
| Zilpaterol | ZILMAX | N141-258 | Type B | For increased rate of weight gain, improved feed efficiency and increased carcass leanness in cattle fed in confinement for slaughter... | OTC |
| Zilpaterol | ZILMAX | N141-258 | Type B (component) | For increased rate of weight gain, improved feed efficiency, and increased carcass leanness in cattle fed in confinement for slaughter during the last 20 to 40 days on feed. | OTC |
| Zilpaterol (Liquid) | ZILMAX | N141-258 | Type B | For increased rate of weight gain, improved feed efficiency and increased carcass leanness in cattle fed in confinement for slaughter... | OTC |
| Zilpaterol (Liquid) | ZILMAX | N141-258 | Type B (component) | For increased rate of weight gain, improved feed efficiency, and increased carcass leanness in cattle fed in confinement for slaughter during the last 20 to 40 days on feed. | OTC |
| Zilpaterol | ZILMAX | N141-258 | Type C | For increased rate of weight gain, improved feed efficiency and increased carcass leanness in cattle fed in confinement for slaughter... | OTC |
| Zilpaterol | ZILMAX | N141-258 | Type C (component) | For increased rate of weight gain, improved feed efficiency, and increased carcass leanness in cattle fed in confinement for slaughter during the last 20 to 40 days on feed. | OTC |
Zilpaterol, Monensin, Tylosin (complete feed) + Melengestrol acetate (complete feed), Melengestrol acetate (liquid complete feed) | ZILMAX, RUMENSIN, TYLAN AND MGA | N141-280 | Type C | For increased rate of weight gain, improved feed efficiency, increased carcass leanness, prevention and control of coccidosis due to Eimeria bovis and E. zuemii and reduction of incidence of liver abscesses caused by Fusobacterium necrophorum and Arcanobacterium (Actinomyces) pyogenes in cattle fed in confinement for slaughter for the last 20 to 40 days on feed. MGA: Heifers Fed in Confinement for Slaughter: For increased rate of weight gain, improved feed efficiency, and suppression of estrus (heat). | VFD (Effective 1/1/17) |
Zilpaterol, Monensin, Tylosin (component feed) + Melengestrol acetate (component feed), Melengestrol acetate (liquid component feed) | ZILMAX, RUMENSIN, TYLAN AND MGA | N141-280 | Type C | For increased rate of weight gain, improved feed efficiency, increased carcass leanness, prevention and control of coccidosis due to Eimeria bovis and E. zuemii and reduction of incidence of liver abscesses caused by Fusobacterium necrophorum and Arcanobacterium (Actinomyces) pyogenes in cattle fed in confinement for slaughter for the last 20 to 40 days on feed. MGA: Heifers Fed in Confinement for Slaughter: For increased rate of weight gain, improved feed efficiency, and suppression of estrus (heat). | VFD (Effective 1/1/17) |
+ | ZILMAX, RUMENSIN AND MGA | N141-282 | Type C | For increased rate of weight gain, improved feed efficiency, increased carcass leanness, and prevention and control of coccidiosis due to Eimeria bovis and E. zuernii in cattle fed in confinement for slaughter for the last 20 to 40 days on feed. MGA: Heifers Fed in Confinement for Slaughter: For increased rate of weight gain, improved feed efficiency, and suppression of estrus (heat). | OTC |
+ | ZILMAX, RUMENSIN AND MGA | N141-282 | Type C (component feeding) | For increased rate of weight gain, improved feed efficiency, increased carcass leanness, and prevention and control of coccidiosis due to Eimeria bovis and E. zuernii in cattle fed in confinement for slaughter for the last 20 to 40 days on feed. MGA: MGA: Heifers Fed in Confinement for Slaughter: For increased rate of weight gain, improved feed efficiency, and suppression of estrus (heat). | OTC |
+ Melengestrol Acetate or Melengestrol Acetate (Liquid) | ZILMAX, RUMENSIN, TYLOVET 100 AND MGA | A200-544 | Type C | For increased rate of weight gain, improved feed efficiency, increased carcass leanness, prevention and control of coccidosis due to Eimeria bovis and E. zuernii and reduction of incidence of liver abscesses caused by Fusobacterium necrophorum and Arcanobacterium (Actinomyces) pyogenes in cattle fed in confinement for slaughter for the last 20 to 40 days on feed. Heifermax: Heifers Fed in Confinement for Slaughter: For Increased Rate of Weight Gain, Improved Feed Efficiency and Suppression of Estrus (Heat). | VFD (Effective 1/1/17) |
| Active Ingredient | Proprietary Name | NADA/ANADA | Label Type | Indications | Marketing Status |
|---|---|---|---|---|---|
| Amprolium | AMPROL | N012-350 | Type B | An aid in the prevention and treatment of coccidiosis caused by Eimeria bovis and E. zurnii in calves. | OTC |
| Amprolium | AMPROL | N012-350 | Type C | An aid in the prevention and treatment of coccidiosis caused by Eimeria bovis and E. zurnii in calves. | OTC |
| As of 1/1/17, this use is no longer approved | |||||
| As of 1/1/17, this use is no longer approved | |||||
| As of 1/1/17, this use is no longer approved | |||||
| As of 1/1/17, this use is no longer approved | |||||
| As of 1/1/17, this use is no longer approved | |||||
| As of 1/1/17, this use is no longer approved | |||||
| Chlortetracycline | CLTC | N092-287 | Type C (milk replacer) | For calves (up to 250 lb) for the treatment of bacterial enteritis caused by E. coli susceptible to chlortetracycline. | VFD (Effective 1/1/17) |
| Chlortetracycline | CLTC | N092-287 | Type C (hand-fed) | For calves (up to 250 lb) for the treatment of bacterial enteritis caused by E. coli susceptible to chlortetracycline. | VFD (Effective 1/1/17) |
| As of 1/1/17, this use is no longer approved | |||||
| As of 1/1/17, this use is no longer approved | |||||
| As of 1/1/17, this use is no longer approved | |||||
| As of 1/1/17, this use is no longer approved | |||||
| As of 1/1/17, this use is no longer approved | |||||
| As of 1/1/17, this use is no longer approved | |||||
| As of 1/1/17, this use is no longer approved | |||||
| Lasalocid | BOVATEC | N096-298 | Type C | For control of coccidiosis caused by Eimeria bovis and Eimeria zuernii in replacement calves | OTC |
| Monensin | MONENSIN | N095-735 | Type C | For calves (excluding veal calves): the prevention and control of coccidiosis caused by Eimeria bovis and Eimeria zuernii. | OTC |
| Neomycin Sulfate and Oxytetracycline | NEO-TERRAMYCIN | N094-975 | Type B | For calves (up to 250 lb) for treatment of bacterial enteritis caused by Escherichia coli susceptible to oxytetracycline; treatment and control of colibacillosis (bacterial enteritis) caused by E. coli susceptible to neomycin. For calves and beef and non-lactating dairy cattle for treatment of bacterial enteritis caused by Escherichia coli and bacterial pneumonia (shipping fever complex) caused by Pasteurella multocida susceptible to oxytetracycline; treatment and control of colibacillosis (bacterial enteritis) caused by E. coli susceptible to neomycin. | VFD (Effective 1/1/17) |
| Neomycin Sulfate and Oxytetracycline | NEO-TERRAMYCIN | N094-975 | Type C | For calves (up to 250 lb) for treatment of bacterial enteritis caused by Escherichia coli susceptible to oxytetracycline; treatment and control of colibacillosis (bacterial enteritis) caused by E. coli susceptible to neomycin. For calves and beef and non-lactating dairy cattle for treatment of bacterial enteritis caused by Escherichia coli and bacterial pneumonia (shipping fever complex) caused by Pasteurella multocida susceptible to oxytetracycline; treatment and control of colibacillosis (bacterial enteritis) caused by E. coli susceptible to neomycin. | VFD (Effective 1/1/17) |
| As of 1/1/17, this use is no longer approved | |||||
| As of 1/1/17, this use is no longer approved | |||||
| As of 1/1/17, this use is no longer approved | |||||
| Neomycin Sulfate and Oxytetracycline | NEO-OXTC | N138-939 | Type B | For use in manufacturing medicated calf feed for use in calf milk replacers or starter feeds. | VFD (Effective 1/1/17) |
| As of 1/1/17, this use is no longer approved | |||||
| As of 1/1/17, this use is no longer approved | |||||
| Neomycin Sulfate and Oxytetracycline | NEO-OXTC | N138-939 | Type C | For treatment of bacterial enteritis caused by Escherichia coli susceptible to oxytetracycline; treatment and control of colibacillosis (bacterial enteritis) caused by Escherichia coli susceptible to neomycin in calves up to 250 lbs for use in milk replacers or starter feeds. | VFD (Effective 1/1/17) |
| As of 1/1/17, this use is no longer approved | |||||
| Oxytetracycline | TERRAMYCIN | N008-804 | Type B | For calves for treatment of bacterial enteritis caused by Escherichia coli susceptible to oxytetracycline. | VFD-12/7/16 |
| Oxytetracycline | TERRAMYCIN | N008-804 | Type C | For calves for treatment of bacterial enteritis caused by Escherichia coli susceptible to oxytetracycline. | VFD-12/7/16 |
| As of 1/1/17, this use is no longer approved | |||||
| As of 1/1/17, this use is no longer approved | |||||
| As of 1/1/17, this use is no longer approved | |||||
| Oxytetracycline | OXTC | N095-143 | Type B | For calves for treatment of bacterial enteritis caused by Escherichia coli susceptible to oxytetracycline. | VFD (Effective 1/1/17) |
| Oxytetracycline | OXTC | N095-143 | Type C | For calves for treatment of bacterial enteritis caused by Escherichia coli susceptible to oxytetracycline. | VFD (Effective 1/1/17) |
| As of 1/1/17, this use is no longer approved | |||||
| Oxytetracycline | OTC | N138-938 | Type B | For use in manufacturing medicated cattle feed. | VFD (Effective 1/1/17) |
| Oxytetracycline | OTC | N138-938 | Type C | For treatment of bacterial enteritis caused by Escherichia coli susceptible to oxytetracycline in calves for use in calf milk replacers or starter feeds. | VFD (Effective 1/1/17) |
| As of 1/1/17, this use is no longer approved | |||||
| As of 1/1/17, this use is no longer approved | |||||
| As of 1/1/17, this use is no longer approved |
| Active Ingredient | Proprietary Name | NADA/ANADA | Label Type | Indications | Marketing Status |
|---|---|---|---|---|---|
| Bambermycins (Liquid) | GAINPRO | N141-034 | Type B | For increased rate of weight gain and improved feed efficiency in cattle fed in confinement for slaughter. | OTC |
| Bambermycins | GAINPRO | N141-034 | Type B | For increased rate of weight gain in pasture cattle (slaughter, stocker and feeder cattle, and dairy and beef replacement heifers). | OTC |
| Bambermycins | GAINPRO | N141-034 | Type C | For increased rate of weight gain and improved feed efficiency in cattle fed in confinement for slaughter. | OTC |
| Bambermycins | GAINPRO | N141-034 | Type C | For increased rate of weight gain in pasture cattle (slaughter, stocker and feeder cattle, and dairy and beef replacement heifers). | OTC |
| Bambermycins | GAINPRO | N141-034 | Type C | For increased rate of weight gain in pasture cattle (slaughter, stocker and feeder cattle, and dairy and beef replacement heifers). | OTC |
| Chlortetracycline | CHLORMAX | N046-699 | Type C | Calves, beef, and non-lactating dairy cattle: For treatment of bacterial enteritis caused by Escherichia coli and for bacterial pneumonia caused by Pasteurella multocida organisms. | VFD (Effective 1/1/17) |
| Chlortetracycline | AUREOMYCIN | N048-761 | Type B | For calves, beef and non-lactating dairy cattle: Treatment of bacterial enteritis caused by Escherichia coli and bacterial pneumonia caused by Pasteurella multocida organisms susceptible to chlortetracycline. | VFD (Effective 1/1/17) |
| Chlortetracycline | AUREOMYCIN | N048-761 | Type C | For calves, beef and non-lactating dairy cattle: Treatment of bacterial enteritis caused by Escherichia coli and bacterial pneumonia caused by Pasteurella multocida organisms susceptible to chlortetracycline. | VFD (Effective 1/1/17) |
| Chlortetracycline | AUREOMYCIN | N048-761 | Type B | For calves, beef and non-lactating dairy cattle: Treatment of bacterial enteritis caused by Escherichia coli and bacterial pneumonia caused by Pasteurella multocida organisms susceptible to chlortetracycline. | VFD (Effective 1/1/17) |
| Chlortetracycline | AUREOMYCIN | N048-761 | Type C | For calves, beef and non-lactating dairy cattle: Treatment of bacterial enteritis caused by Escherichia coli and bacterial pneumonia caused by Pasteurella multocida organisms susceptible to chlortetracycline. | VFD (Effective 1/1/17) |
| Chlortetracycline | AUREOMYCIN | N048-761 | Type C | For beef and non-lactating dairy cattle: as an aid in the control of active infection of anaplasmosis caused by Anaplasma marginale susceptible to chlortetracycline. | VFD (Effective 1/1/17) |
| Chlortetracycline | CHLORATET | N048-480 | Type B | Calves, Beef and Non-Lactating Dairy Cattle: For treatment of bacterial enteritis caused by Escherichia coli and bacterial pneumonia caused by Pasteurella multocida organisms susceptible to Chlortetracycline. | VFD (Effective 1/1/17) |
| Chlortetracycline | CHLORATET | N048-480 | Type C | Calves, Beef and Non-Lactating Dairy Cattle: For treatment of bacterial enteritis caused by Escherichia coli and bacterial pneumonia caused by Pasteurella multocida organisms susceptible to Chlortetracycline. | VFD (Effective 1/1/17) |
| Chlortetracycline | CLTC | N092-286 | Type C | For calves, beef and nonlactating dairy cattle, for treatment of bacterial enteritis caused by E. coli and bacterial pneumonia caused by P. multocida organisms susceptible to chlortetracycline. | VFD (Effective 1/1/17) |
| Chlortetracycline | PENNCHLOR | N138-935 | Type B | For use in manufacturing medicated cattle feed. | VFD (Effective 1/1/17) |
| Chlortetracycline | PENNCHLOR | N138-935 | Type C | For the treatment of bacterial enteritis caused by Escherichia coli and bacterial pneumonia caused by Pasteurella multocida organisms susceptible to chlortetracycline in calves, beef and non-lactating dairy cattle. | VFD (Effective 1/1/17) |
| Chlortetracycline | DERACIN | A200-510 | Type B | For calves, beef and non-lactating dairy cattle: Treatment of bacterial enteritis caused by Escherichia coli and bacterial pneumonia caused by Pasteurella multocida organisms susceptible to chlortetracycline. | VFD (Effective 1/1/17) |
| Chlortetracycline | DERACIN | A200-510 | Type C - top-dress | For calves, beef and non-lactating dairy cattle: Treatment of bacterial enteritis caused by Escherichia coli and bacterial pneumonia caused by Pasteurella multocida organisms susceptible to chlortetracycline. | VFD (Effective 1/1/17) |
| Chlortetracycline | DERACIN | A200-510 | Type B | For calves, beef and non-lactating dairy cattle: Treatment of bacterial enteritis caused by Escherichia coli and bacterial pneumonia caused by Pasteurella multocida organisms susceptible to chlortetracycline. | VFD (Effective 1/1/17) |
| Chloretracycline | DERACIN | A200-510 | Type C | For calves, beef and non-lactating dairy cattle: Treatment of bacterial enteritis caused by Escherichia coli and bacterial pneumonia caused by Pasteurella multocida organisms susceptible to chlortetracycline. | VFD (Effective 1/1/17) |
| Chlortetracycline | DERACIN | A200-510 | Type C - free-choice mineral | For beef and non-lactating dairy cattle: as an aid in the control of active infection of anaplasmosis caused by Anaplasma marginale susceptible to chlortetracycline. | VFD (Effective 1/1/17) |
| Chlortetracycline and Laidlomycin propionate potassium | AUREOMYCIN, CATTLYST | N141-201 | Type B | For the treatment of bacterial enteritis caused by E. coli and bacterial pneumonia caused by P. multocida organisms susceptible to chlortetracycline, and for improved feed efficiency and increased rate of weight gain in cattle fed in confinement for slaughter. | VFD (Effective 1/1/17) |
| Chlortetracycline and Laidlomycin propionate potassium | AUREOMYCIN, CATTLYST | N141-201 | Type B | For the treatment of bacterial enteritis caused by E. coli and bacterial pneumonia caused by P. multocida organisms susceptible to chlortetracycline, and for improved feed efficiency in cattle fed in confinement for slaughter. | VFD (Effective 1/1/17) |
| Chlortetracycline and Laidlomycin propionate potassium | AUREOMYCIN, CATTLYST | N141-201 | Type B | For control of bacterial pneumonia associated with shipping fever complex caused by Pasteurella spp. susceptible to chlortetracycline, and for improved feed efficiency in beef cattle fed in confinement for slaughter. | VFD (Effective 1/1/17) |
| Chlortetracycline and Laidlomycin propionate potassium | AUREOMYCIN, CATTLYST | N141-201 | Type C | For control of bacterial pneumonia associated with shipping fever complex caused by Pasteurella spp. susceptible to chlortetracycline, and for improved feed efficiency and increased rate of weight gain in beef cattle fed in confinement for slaughter. | VFD (Effective 1/1/17) |
| Chlortetracycline and Laidlomycin propionate potassium | AUREOMYCIN, CATTLYST | N141-201 | Type C | For the treatment of bacterial enteritis caused by E. coli and bacterial pneumonia caused by P. multocida organisms susceptible to chlortetracycline, and for improved feed efficiency and increased rate of weight gain in cattle fed in confinement for slaughter. | VFD (Effective 1/1/17) |
| Chlortetracycline and Laidlomycin propionate potassium | AUREOMYCIN, CATTLYST | N141-201 | Type C | For control of bacterial pneumonia associated with shipping fever complex caused by Pasteurella spp.-susceptible to chlortetracycline, and for improved feed efficiency in beef cattle fed in confinement for slaughter. | VFD (Effective 1/1/17) |
| Chlortetracycline and Laidlomycin propionate potassium | AUREOMYCIN, CATTLYST | N141-201 | Type C | For the treatment of bacterial enteritis caused by E. coli and bacterial pneumonia caused by P. multocida organisms susceptible to chlortetracycline, and for improved feed efficiency and increased rate of weight gain in cattle fed in confinement for slaughter. | VFD (Effective 1/1/17) |
| Chlortetracycline and Laidlomycin propionate potassium | AUREOMYCIN | N141-201 | Type B | For control of bacterial pneumonia associated with shipping fever complex caused by Pasteurella spp. susceptible to chlortetracycline, and for improved feed efficiency and increased rate of weight gain in beef cattle fed in confinement for slaughter. | VFD (Effective 1/1/17) |
| Chlortetracycline and Sulfamethazine | AUREO S | N035-805 | Type B | As an aid in the maintenance of weight gains in the presence of respiratory disease such as shipping fever. | VFD (Effective 1/1/17) |
| Chlortetracycline and Sulfamethazine | AUREO S | N035-805 | Type C | As an aid in the maintenance of weight gains in the presence of respiratory disease such as shipping fever. | VFD (Effective 1/1/17) |
| Chlortetracycline and Sulfamethazine | PENNCHLOR S | A200-314 | Type B | As an aid in the maintenance of weight gains in the presence of respiratory disease such as shipping fever. | VFD (Effective 1/1/17) |
| Chlortetracycline and Sulfamethazine | PENNCHLOR S | A200-314 | Type C | As an aid in the maintenance of weight gains in the presence of respiratory disease such as shipping fever. | VFD (Effective 1/1/17) |
| Decoquinate | DECCOX | N039-417 | Type B | For the prevention of coccidiosis in cattle (including ruminating and non-ruminating calves and veal calves) caused by Eimeria bovis and E. zuernii. | OTC |
| Decoquinate (liquid) | DECCOX | N039-417 | Type B | For the prevention of coccidiosis in cattle (including ruminating and non-ruminating calves and veal calves) caused by Eimeria bovis and E. zuernii. | OTC |
| Decoquinate and Chlortetracycline | DECCOX, DERACIN | A200-622 | Type B | Calves, beef and non-lactating dairy cattle. For the prevention of coccidiosis caused by Eimeria bovis and E. zuernii, for treatment of bacterial enteritis caused by Escherichia coli and bacterial pneumonia caused by Pasteurella multocida organisms susceptible to chlortetracycline. | VFD (Effective 1/1/17) |
| Decoquinate and Chlortetracycline | DECCOX, DERACIN | A200-622 | Type C | Calves, beef, and non-lactating dairy cattle: For the prevention of coccidiosis caused by Eimeria bovis and E. zuernii; for treatment of bacterial enteritis caused by Escherichia coli and bacterial pneumonia caused by Pasteurella multocida organisms susceptible to chlortetracycline. | VFD (Effective 1/1/17) |
| Decoquinate and Chlortetracycline | DECCOX, DERACIN | A200-622 | Type C | Calves, beef, and non-lactating dairy cattle: For the prevention of coccidiosis caused by Eimeria bovis and E. zuernii; for treatment of bacterial enteritis caused by Escherichia coli and bacterial pneumonia caused by Pasteurella multocida organisms susceptible to chlortetracycline. | VFD (Effective 1/1/17) |
| Decoquinate and Chlortetracycline | CHLOROMAX, DECCOX | N141-147 | Type B | Calves, beef and non-lactating dairy cattle. For the prevention of coccidiosis caused by Eimeria bovis and E. zuernii; for treatment of bacterial enteritis caused by Escherichia coli and bacterial pneumonia caused by Pasteurella multocida organisms susceptible to chlortetracycline. | VFD (Effective 1/1/17) |
| Decoquinate and Chlortetracycline | CHLOROMAX, DECCOX | N141-147 | Type C | Calves, beef, and non-lactating dairy cattle. For the prevention of coccidiosis caused by Eimeria bovis and E. zuernii; for treatment of bacterial enteritis caused by Escherichia coli and bacterial pneumonia caused by Pasteurella multocida organisms susceptible to chlortetracycline. | VFD (Effective 1/1/17) |
| Decoquinate and Chlortetracycline | CHLOROMAX, DECCOX | N141-147 | Type C | Calves, beef, and non-lactating dairy cattle. For the prevention of coccidiosis caused by Eimeria bovis and E. zuernii; for treatment of bacterial enteritis caused by Escherichia coli and bacterial pneumonia caused by Pasteurella multocida organisms susceptible to chlortetracycline. | VFD (Effective 1/1/17) |
| Decoquinate and Chlortetracycline | AEUROMYCIN, DECCOX | N141-185 | Type B | Calves, beef, and non-lactating dairy cattle. For the prevention of coccidiosis caused by Eimeria bovis and E. zuernii; for treatment of bacterial enteritis caused by Escherichia coli and bacterial pneumonia caused by Pasteurella multocida organisms susceptible to chlortetracycline. | VFD (Effective 1/1/17) |
| Decoquinate and Chlortetracycline | AEUROMYCIN, DECCOX | N141-185 | Type C (top-dress) | Calves, beef, and non-lactating dairy cattle. For the prevention of coccidiosis caused by Eimeria bovis and E. zuernii; for treatment of bacterial enteritis caused by Escherichia coli and bacterial pneumonia caused by Pasteurella multocida organisms susceptible to chlortetracycline. | VFD (Effective 1/1/17) |
| Decoquinate and Chlortetracycline | AEUROMYCIN, DECCOX | N141-185 | Type C | Calves, beef, and non-lactating dairy cattle. For the prevention of coccidiosis caused by Eimeria bovis and E. zuernii; for treatment of bacterial enteritis caused by Escherichia coli and bacterial pneumonia caused by Pasteurella multocida organisms susceptible to chlortetracycline. | VFD (Effective 1/1/17) |
| Decoquinate and Chlortetracycline | PENNCHLOR, DECCOX | A200-359 | Type B | Calves, beef and non-lactating dairy cattle. For the prevention of coccidiosis caused by Eimeria bovis and E. zuernii; for treatment of bacterial enteritis caused by Escherichia coli and bacterial pneumonia caused by Pasteurella multocida organisms susceptible to chlortetracycline. | VFD (Effective 1/1/17) |
| Decoquinate and Chlortetracycline | PENNCHLOR, DECCOX | A200-359 | Type C | Calves, beef and non-lactating dairy cattle. For the prevention of coccidiosis caused by Eimeria bovis and E. zuernii; for treatment of bacterial enteritis caused by Escherichia coli and bacterial pneumonia caused by Pasteurella multocida organisms susceptible to chlortetracycline. | VFD (Effective 1/1/17) |
| Decoquinate and Chlortetracycline | PENNCHLOR, DECCOX | A200-359 | Type C | Calves, beef and non-lactating dairy cattle. For the prevention of coccidiosis caused by Eimeria bovis and E. zuernii; for treatment of bacterial enteritis caused by Escherichia coli and bacterial pneumonia caused by Pasteurella multocida organisms susceptible to chlortetracycline. | VFD (Effective 1/1/17) |
| Decoquinate and Monensin sodium | DECCOX, RUMENSIN | N141-148 | Type B | For the prevention of coccidiosis caused by Eimeria bovis and E. zuernii, and improved feed efficiency in cattle being fed in confinement for slaughter. | OTC |
| Decoquinate and Monensin sodium | DECCOX, RUMENSIN | N141-148 | Type B | For the prevention of coccidiosis caused by Eimeria bovis and E. zuernii, and improved feed efficiency in cattle being fed in confinement for slaughter. | OTC |
| Fenbendazole | SAFE-GUARD | N131-675 | Type B | For the removal and control of: Lungworms: (Dictyocaulus viviparus) Stomach worms: Barberpole worms (Haemonchus contortus), brown stomach worms (Ostertagia ostertagi), small stomach worms (Trichostrongylus axei) Intestinal worms: Hookworms (Bunostomum phlebotomum), thread-necked intestinal worms (Nematodirus helvetianus), small intestinal worms (Cooperia punctata & C. oncophora) Bankrupt worms: (Trichostrongylus colubriformis) Nodular worms: (Oesophaogostomum radiatum) | OTC |
| Fenbendazole | SAFE-GUARD | N131-675 | Type C | For the removal and control of: Lungworms: (Dictyocaulus viviparus) Stomach worms: Barberpole worms (Haemonchus contortus), brown stomach worms (Ostertagia ostertagi), small stomach worms (Trichostrongylus axei) Intestinal worms: Hookworms (Bunostomum phlebotomum), thread-necked intestinal worms (Nematodirus helvetianus), small intestinal worms (Cooperia punctata & C. oncophora) Bankrupt worms: (Trichostrongylus colubriformis) Nodular worms: (Oesophaogostomum radiatum) | OTC |
| Lasalocid | BOVATEC | N096-298 | Type B | For control of coccidiosis caused by Eimeria bovis and Eimeria zuernii in cattle up to 800 lbs. | OTC |
| Lasalocid | BOVATEC | N096-298 | Type C | For control of coccidiosis caused by Eimeria bovis and Eimeria zuernii in cattle up to 800 lbs. | OTC |
| Lasalocid | BOVATEC | N096-298 | Type B | For increased rate of weight gain in pasture cattle (slaughter, stocker, feeder cattle, and dairy and beef replacement heifers). | OTC |
| Lasalocid | BOVATEC | N096-298 | Type C | For increased rate of weight gain in pasture cattle (slaughter, stocker, feeder cattle, and dairy and beef replacement heifers). | OTC |
| Lasalocid (Liquid) | BOVATEC | N096-298 | Type B | For control of coccidiosis caused by Eimeria bovis and Eimeria zuernii in cattle up to 800 lbs. | OTC |
| Lasalocid (Liquid) | BOVATEC | N096-298 | Type B | For increased rate of weight gain in pasture cattle (slaughter, stocker, feeder cattle, and dairy and beef replacement heifers). | OTC |
| Melengestrol Acetate, Monensin (Liquid) | HEIFERMAX AND RUMENSIN | A200-422 | Type C | For Beef and Dairy Heifers...Increased rate of weight gain, improved feed efficiency, suppression of estrus (heat), and prevention and control of coccidiosis due to Eimeria bovis and Eimeria zuernii. | OTC |
| Melengestrol Acetate, Monensin | HEIFERMAX AND RUMENSIN | A200-422 | Type C | For Beef and Dairy Heifers...Increased rate of weight gain, improved feed efficiency, suppression of estrus (heat), and prevention and control of coccidiosis due to Eimeria bovis and Eimeria zuernii. | OTC |
| Melengestrol Acetate, Monensin, Tylosin | MGA, RUMENSIN AND TYLAN | N138-870 | Type C | Increased rate of weight gain, improved feed efficiency, suppression of estrus (heat), prevention and control of coccidiosis..., reduction of incidence of liver abscesses... | VFD (Effective 1/1/17) |
| Melengestrol Acetate, Monensin, Tylosin (Liquid) | MGA, RUMENSIN AND TYLAN | N138-870 | Type C | Increased rate of weight gain, improved feed efficiency, suppression of estrus (heat), prevention and control of coccidiosis..., reduction of incidence of liver abscesses... | VFD (Effective 1/1/17) |
| Melengestrol Acetate and Tylosin Phosphate | MGA and TYLAN | N139-192 | Type C | For increased rate of weight gain, improved feed efficiency, suppression of estrus (heat), and reduced incidence of liver abscesses ... | VFD (Effective 1/1/17) |
| Melengestrol Acetate and Tylosin Phosphate (Liquid) | MGA and TYLAN | N139-192 | Type C | For increased rate of weight gain, improved feed efficiency, suppression of estrus (heat), and reduced incidence of liver abscesses ... | VFD (Effective 1/1/17) |
| Melengestrol Acetate and Tylosin Phosphate (Liquid) | MGA AND TYLOVET | A200-532 | Type C | Heifers being fed in confinement for slaughter: For increased rate of weight gain, improved feed efficiency, suppression of estrus (heat), and reduced incidence of liver abscesses caused by Fusobacterium necrophorum and Arcanobacterium (Actinomyces) pyogenes | VFD (Effective 1/1/17) |
| Melengestrol Acetate and Tylosin Phosphate | MGA AND TYLOVET | A200-532 | Type C | Heifers being fed in confinement for slaughter: For increased rate of weight gain, improved feed efficiency, suppression of estrus (heat), and reduced incidence of liver abscesses caused by Fusobacterium necrophorum and Actinomyces (Corynebacterium) pyogenes | VFD (Effective 1/1/17) |
| Melengestrol acetate, Monensin, and Tylosin phosphate (Liquid) | MGA, RUMENSIN AND TYLOVET | A200-534 | Type C | Increased rate of weight gain, improved feed efficiency, suppression of estrus (heat), prevention and control of coccidiosis due to Eimeria bovis and Eimeria zuernii, reduction of incidence of liver abscesses caused by Fusobacterium necrophorum and Arcanobacterium pyogenes in heifers fed in confinement for slaughter. | VFD (Effective 1/1/17) |
| Melengestrol acetate, Monensin, and Tylosin phosphate | MGA, RUMENSIN AND TYLOVET | A200-534 | Type C | Increased rate of weight gain, improved feed efficiency, suppression of estrus (heat), prevention and control of coccidiosis due to Eimeria bovis and Eimeria zuernii, reduction of incidence of liver abscesses caused by Fusobacterium necrophorum and Arcanobacterium pyogenes in heifers fed in confinement for slaughter. | VFD (Effective 1/1/17) |
| Monensin | MONENSIN | N095-735 | Type B | For increased rate of weight gain; For prevention and control of coccidiosis caused by Eimeria bovis and Eimeria zuernii in growing cattle on pasture or in dry lot (stocker and feeder cattle and dairy and beef replacement heifers). | OTC |
| Monensin | MONENSIN | N095-735 | Type C | For increased rate of weight gain; For prevention and control of coccidiosis caused by Eimeria bovis and Eimeria zuernii in growing cattle on pasture or in dry lot (stocker and feeder cattle and dairy and beef replacement heifers). | OTC |
| Morantel tartrate | RUMANTEL | N092-444 | Type C | For the removal and control of mature gastrointestinal nematode infections of cattle including stomach worms (Haemonchus spp., Ostertagia spp., Trichostrongylus spp.), worms of the small intestine (Cooperia spp., Trichostrongylus spp., Nematodirus spp.), and worms of large intestine (Oesophagostomum radiatum). | OTC |
Ractopamine, Monensin, Tylosin + Melengestrol acetate or Liquid Melengestrol acetate | OPTAFLEXX, RUMENSIN, TYLOVET, MGA | A200-567 | Type C | For increased rate of weight gain, improved feed efficiency, increased carcass leanness, prevention and control of coccidiosis due to Eimeria bovis and E. zuernii and reduction of incidence of liver abscesses caused by Fusobacterium necrophorum and Arcanobacterium (Actinomyces) pyogenes in cattle fed in confinement for slaughter for the last 28 to 42 days on feed. MGA: Heifers fed in confinement for slaughter: for increased rate of weight gain, improved feed efficiency and suppression of estrus (heat). | VFD (Effective 1/1/17) |
| Neomycin Sulfate and Oxytetracycline | NEO-TERRAMYCIN | N094-975 | Type B | For growing cattle (over 400 lb) for reduction of liver condemnation due to liver abscesses. | VFD (Effective 1/1/17) |
| Neomycin Sulfate and Oxytetracycline | NEO-TERRAMYCIN | N094-975 | Type C | For growing cattle (over 400 lb) for reduction of liver condemnation due to liver abscesses. | VFD (Effective 1/1/17) |
| Neomycin Sulfate and Oxytetracycline | NEO-TERRAMYCIN | N094-975 | Type B | For cattle for prevention and treatment of the early stages of shipping fever complex | VFD (Effective 1/1/17) |
| Neomycin Sulfate and Oxytetracycline | NEO-TERRAMYCIN | N094-975 | Type C | For cattle for prevention and treatment of the early stages of shipping fever complex | VFD (Effective 1/1/17) |
| Neomycin Sulfate and Oxytetracycline | NEO-TERRAMYCIN | N094-975 | Type B | For calves and beef and non-lactating dairy cattle for treatment of bacterial enteritis caused by Escherichia coli and bacterial pneumonia (shipping fever complex) caused by Pasteurella multocida susceptible to oxytetracycline; treatment and control of colibacillosis (bacterial enteritis) caused by E. coli susceptible to neomycin. | VFD (Effective 1/1/17) |
| Neomycin Sulfate and Oxytetracycline | NEO-TERRAMYCIN | N094-975 | Type C | For calves and beef and non-lactating dairy cattle for treatment of bacterial enteritis caused by Escherichia coli and bacterial pneumonia (shipping fever complex) caused by Pasteurella multocida susceptible to oxytetracycline; treatment and control of colibacillosis (bacterial enteritis) caused by E. coli susceptible to neomycin. | VFD (Effective 1/1/17) |
| Neomycin Sulfate and Oxytetracycline | NEO-OXTC | N138-939 | Type B | For use in manufacturing medicated cattle feed. | VFD (Effective 1/1/17) |
| Neomycin Sulfate and Oxytetracycline | NEO-OXTC | N138-939 | Type C | For treatment of bacterial enteritis caused by Escherichia coli and bacterial pneumonia (shipping fever complex) caused by Pasteurella multocida susceptible to oxytetracycline; treatment and control of colibacillosis (bacterial enteritis) caused by Escherichia coli susceptible to neomycin in calves, beef and non-lactating dairy cattle. | VFD (Effective 1/1/17) |
| Neomycin Sulfate and Oxytetracycline | NEO-OXTC | N138-939 | Type C | For prevention and treatment of the early stages of shipping fever complex. | VFD (Effective 1/1/17) |
| Oxytetracycline | TERRAMYCIN | N008-804 | Type B | For calves and beef and non-lactating dairy cattle for treatment of bacterial enteritis caused by Escherichia coli and bacterial pneumonia (shipping fever complex) caused by Pasteurella multocida susceptible to oxytetracycline. | VFD (Effective 1/1/17) |
| Oxytetracycline | TERRAMYCIN | N008-804 | Type C | For calves and beef and nonlactating dairy cattle, for treatment of bacterial enteritis caused by Escherichia coli and bacterial pneumonia (shipping fever complex) caused by Pasteurella multocida susceptible to oxytetracycline. | VFD (Effective 1/1/17) |
| Oxytetracycline | TERRAMYCIN | N008-804 | Type B | For calves, beef cattle and nonlactating dairy cattle for prevention and treatment of the early stages of shipping fever complex. | VFD (Effective 1/1/17) |
| Oxytetracycline | TERRAMYCIN | N008-804 | Type C | For calves, beef cattle, and nonlactating dairy cattle for prevention and treatment of the early stages of shipping fever complex. | VFD (Effective 1/1/17) |
| Oxytetracycline | OXTC | N095-143 | Type B | For growing cattle (over 400 lb) for reduction of liver condemnation due to liver abscesses. | VFD (Effective 1/1/17) |
| Oxytetracycline | OXTC | N095-143 | Type C | For growing cattle (over 400 lb) for reduction of liver condemnation due to liver abscesses. | VFD (Effective 1/1/17) |
| Oxytetracycline | OXTC | N095-143 | Type B | For calves, beef cattle and nonlactating dairy cattle for prevention and treatment of the early stages of shipping fever complex. | VFD (Effective 1/1/17) |
| Oxytetracycline | OXTC | N095-143 | Type C | For calves, beef cattle, and nonlactating dairy cattle for prevention and treatment of the early stages of shipping fever complex. | VFD (Effective 1/1/17) |
| Oxytetracycline | OXTC | N095-143 | Type B | For calves and beef and non-lactating dairy cattle for treatment of bacterial enteritis caused by Escherichia coli and bacterial pneumonia (shipping fever complex) caused by Pasteurella multocida susceptible to oxytetracycline. | VFD (Effective 1/1/17) |
| Oxytetracycline | OXTC | N095-143 | Type C | For calves and beef and nonlactating dairy cattle, for treatment of bacterial enteritis caused by Escherichia coli and bacterial pneumonia (shipping fever complex) caused by Pasteurella multocida susceptible to oxytetracycline. | VFD (Effective 1/1/17) |
| Oxytetracycline | OTC | N138-938 | Type B | For use in manufacturing medicated calf feed for use in calf milk replacers or starter feeds. | VFD (Effective 1/1/17) |
| Oxytetracycline | OTC | N138-938 | Type C | For the prevention and treatment of the early stages of the shipping fever complex. | VFD (Effective 1/1/17) |
| Oxytetracycline | OTC | N138-938 | Type C | For treatment of bacterial enteritis caused by Escherichia coli and bacterial pneumonia (shipping fever complex) caused by Pasteurella multocida organisms susceptible to oxytetracycline in calves, beef and non-lactating dairy cattle. | VFD (Effective 1/1/17) |
| Poloxalene | BLOAT GUARD | N032-704 | Type C | For prevention of legume (alfalfa, clover) and wheat pasture bloat in cattle. | OTC |
| Poloxalene | BLOAT GUARD | N038-281 | Type C | For control of legume (alfalfa, clover) and wheat pasture bloat in cattle. | OTC |
| Poloxalene | BLOAT GUARD | N038-281 | Type C | For control of legume (alfalfa, clover) and wheat pasture bloat in cattle. | OTC |
| Tilmicosin | PULMOTIL | N141-064 | Type B | For the control of bovine respiratory disease (BRD) associated with Mannheimia haemolytica, Pasteurella multocida, and Histophilus somni in groups of beef and non-lactating dairy cattle, where active BRD has been diagnosed in at least 10% of the animals in the group. | VFD |
| Tilmicosin | PULMOTIL | N141-064 | Type C | For the control of bovine respiratory disease (BRD) associated with Mannheimia haemolytica, Pasteurella multocida, and Histophilus somni in groups of beef and non-lactating dairy cattle, where active BRD has been diagnosed in at least 10% of the animals in the group. | VFD |
| Tilmicosin | TILMOVET | A200-509 | Type B | For the control of bovine respiratory disease (BRD) associated with Mannheimia haemolytica, Pasteurella multocida, and Histophilus somni in groups of beef and non-lactating dairy cattle, where active BRD has been diagnosed in at least 10% of the animals in the group. | VFD |
| Tilmicosin | TILMOVET | A200-509 | Type C | For the control of bovine respiratory disease (BRD) associated with Mannheimia haemolytica, Pasteurella multocida, and Histophilus somni in groups of beef and non-lactating dairy cattle, where active BRD has been diagnosed in at least 10% of the animals in the group. | VFD |
| Tylosin (Liquid) | TYLAN | N012-491 | Type B | For reduction of incidence of liver abscesses associated with Fusobacterium necrophorum and Arcanobacterium pyogenes. | VFD (Effective 1/1/17) |
| Tylosin | TYLAN | N012-491 | Type B | For reduction of incidence of liver abscesses associated with Fusobacterium necrophorum and Arcanobacterium pyogenes. | VFD (Effective 1/1/17) |
| Tylosin | TYLAN | N012-491 | Type C | For reduction of incidence of liver abscesses associated with Fusobacterium necrophorum and Arcanobacterium pyogenes. | VFD (Effective 1/1/17) |
| Tylosin phosphate | TYLOVET | A200-484 | Type C | For reduction of incidence of liver abscesses caused by Fusobacterium necrophorum and Arcanobacterium (Actinomyces) pyogenes. | VFD (Effective 1/1/17) |
| Tylosin phosphate | TYLOVET | A200-484 | Type B | For reduction of incidence of liver abscesses caused by Fusobacterium necrophorum and Arcanobacterium (Actinomyces) pyogenes. | VFD (Effective 1/1/17) |
| Tylosin phosphate (liquid) | TYLOVET | A200-484 | Type B | For reduction of incidence of liver abscesses caused by Fusobacterium necrophorum and Arcanobacterium (Actinomyces) pyogenes. | VFD (Effective 1/1/17) |
| Tylosin phosphate, Melengestrol acetate | TYLOVET | A200-484 | Type C | For increased rate of weight gain, improved feed efficiency, suppression of estrus (heat), and for reduction of incidence of liver abscesses associated with Fusobacterium necrophorum and Arcanobacterium pyogenes. | VFD (Effective 1/1/17) |
| As of 1/1/17, this use is no longer approved. | |||||
| As of 1/1/17, this use is no longer approved. | |||||
| As of 1/1/17, this use is no longer approved. | |||||
| As of 1/1/17, this use is no longer approved. | |||||
| Virginiamycin | V-MAX | N140-998 | Type B | For reduction of incidence of liver abscesses. | VFD (Effective 1/1/17) |
| Virginiamycin | V-MAX | N140-998 | Type C | For reduction of incidence of liver abscesses. | VFD (Effective 1/1/17) |
| Zilpaterol | ZILMAX, HEIFERMAX | A200-483 | Type B | For increased rate of weight gain, improved feed efficiency and increased carcass leanness in cattle fed in confinement for slaughter during the last 20 to 40 days on feed. | OTC |
+ | ZILMAX, HEIFERMAX | A200-483 | Type C | For increased rate of weight gain, improved feed efficiency and increased carcass leanness in cattle fed in confinement for slaughter during the last 20 to 40 days on feed. Heifermax: For Beef and Dairy Heifers...Heifers Fed in Confinement for Slaughter: For Increased Rate of Weight Gain, Improved Feed Efficiency and Suppression of Estrus (Heat). | OTC |
| Zilpaterol (Liquid) | ZILMAX, HEIFERMAX | A200-483 | Type B | For increased rate of weight gain, improved feed efficiency and increased carcass leanness in cattle fed in confinement for slaughter during the last 20 to 40 days on feed. | OTC |
| ZILMAX, RUMENSIN | A200-479 | Type B | For increased rate of weight gain, improved feed efficiency, increased carcass leanness, and prevention and control of coccidiosis... | OTC | |
| Zilpaterol and Monensin (Liquid) | ZILMAX, RUMENSIN | A200-479 | Type B | For increased rate of weight gain, improved feed efficiency, increased carcass leanness, and prevention and control of coccidiosis... | OTC |
| ZILMAX, RUMENSIN, HEIFERMAX | A200-479 | Type C | For increased rate of weight gain, improved feed efficiency, increased carcass leanness, and prevention and control of coccidiosis... Heifermax: For Beef and Dairy Heifers...Heifers Fed in Confinement for Slaughter: For Increased Rate of Weight Gain, Improved Feed Efficiency and Suppression of Estrus (Heat). | OTC | |
Zilpaterol, Monensin, and Tylosin Phosphate + | ZILMAX, RUMENSIN, TYLAN, AND HEIFERMAX | A200-480 | Type C | For increased rate of weight gain, improved feed efficiency, increased carcass leanness, prevention and control of coccidiosis ... and reduction of incidence of liver abscesses ... in cattle fed in confinement for slaughter for the last 20 to 40 days on feed. Heifermax: For Beef and Dairy Heifers...Heifers Fed in Confinement for Slaughter: For Increased Rate of Weight Gain, Improved Feed Efficiency and Suppression of Estrus (Heat). | VFD (Effective 1/1/17) |
| Active Ingredient | Proprietary Name | NADA/ANADA | Label Type | Indications | Marketing Status |
|---|---|---|---|---|---|
| Monensin (Liquid) | MONENSIN | N095-735 | Type B | For increased milk production efficiency (production of marketable solids-corrected milk per unit of feed intake). | OTC |
| Monensin | MONENSIN | N095-735 | Type B | For increased milk production efficiency (production of marketable solids-corrected milk per unit of feed intake). | OTC |
| Monensin | MONENSIN | N095-735 | Type C | For total mixed rations: increased milk production efficiency (production of marketable solids-corrected milk per unit of feed intake). | OTC |
| Monensin | MONENSIN | N095-735 | Type C | For component feeding systems (including top dress): increased milk production efficiency (production of marketable solids-corrected milk per unit of feed intake). | OTC |
| Active Ingredient | Proprietary Name | NADA/ANADA | Label Type | Indications | Marketing Status |
|---|---|---|---|---|---|
| Bacitracin Zinc | ALBAC | A200-223 | Type B | For an increased rate of weight gain and improved feed efficiency. | OTC |
| Bacitracin Zinc | ALBAC | A200-223 | Type C | For an increased rate of weight gain and improved feed efficiency. | OTC |
| Chlortetracycline | CHLORMAX | N046-699 | Type C | For the reduction of the incidence of liver abscesses | VFD (Effective 1/1/17) |
| Chlortetracycline | CHLORATET | N048-480 | Type B | For the reduction of the incidence of liver abscesses | VFD (Effective 1/1/17) |
| Chlortetracycline | CHLORATET | N048-480 | Type C | For the reduction of the incidence of liver abscesses | VFD (Effective 1/1/17) |
| Chlortetracycline | CLTC | N092-286 | Type C | For growing cattle (over 400 lb) for reduction of the incidence of liver abscesses. | VFD (Effective 1/1/17) |
| Chlortetracycline | PENNCHLOR | N138-935 | Type C | For the reduction of the incidence of liver abscesses in growing cattle over 400 lbs. | VFD (Effective 1/1/17) |
| Chlortetracycline | DERACIN | A200-510 | Type B | For the reduction of the incidence of liver abscesses in growing cattle over 400 lbs. | VFD (Effective 1/1/17) |
| Chlortetracycline | DERACIN | A200-510 | Type C | For the reduction of the incidence of liver abscesses in growing cattle over 400 lbs. | VFD (Effective 1/1/17) |
| Monensin | MONENSIN | N095-735 | Type B | For increased rate of weight gain; prevention and control of coccidiosis caused by Eimeria bovis and Eimeria zuernii in growing cattle on pasture or in dry lot (stocker and feeder cattle and dairy and beef replacement heifers). | OTC |
| Monensin | MONENSIN | N095-735 | Type C | For increased rate of weight gain; prevention and control of coccidiosis caused by Eimeria bovis and Eimeria zuernii in growing cattle on pasture or in dry lot (stocker and feeder cattle and dairy and beef replacement heifers). | OTC |
| Neomycin Sulfate and Oxytetracycline | NEO-OXTC | N138-939 | Type C | For the reduction of the incidence of liver abscesses in growing cattle over 400 lbs. | VFD (Effective 1/1/17) |
| Oxytetracycline | TERRAMYCIN | N008-804 | Type B | For growing cattle (over 400 lb) for the reduction of incidence of liver abscesses. | VFD (Effective 1/1/17) |
| Oxytetracycline | TERRAMYCIN | N008-804 | Type C | For growing cattle (over 400 lb) for the reduction of incidence of liver abscesses. | VFD (Effective 1/1/17) |
| Oxytetracycline | OTC | N138-938 | Type C | For the reduction of the incidence of liver abscesses in growing cattle over 400 lbs. | VFD (Effective 1/1/17) |
| Active Ingredient | Proprietary Name | NADA/ANADA | Label Type | Indications | Marketing Status |
|---|---|---|---|---|---|
| Monensin | MONENSIN | N095-735 | Type B | For mature reproducing beef cows (on pasture or in dry lot): improved feed efficiency when receiving supplemental feed; prevention and control of coccidiosis caused by Eimeria bovis and Eimeria zuernii. | OTC |
| Monensin | MONENSIN | N095-735 | Type C | For mature reproducing beef cows (on pasture or in dry lot): improved feed efficiency when receiving supplemental feed; prevention and control of coccidiosis caused by Eimeria bovis and Eimeria zuernii. | OTC |